George Perry, AA, BA, PhD, HonD - Publications

Affiliations: 
Biology The University of Texas at San Antonio, San Antonio, TX, United States 
Area:
Alzheimer's disease, oxidative stress, cytoskeleton
Website:
https://www.utsa.edu/sciences/labs/GeorgePerry/

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Plascencia-Villa G, Perry G. Neuropathologic Changes Provide Insights into Key Mechanisms Related to Alzheimer Disease and Related Dementia. The American Journal of Pathology. PMID 35931209 DOI: 10.1016/j.ajpath.2022.07.002  0.417
2022 Ashford JW, Schmitt FA, Bergeron MF, Bayley PJ, Clifford JO, Xu Q, Liu X, Zhou X, Kumar V, Buschke H, Dean M, Finkel SI, Hyer L, Perry G. Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement. Journal of Alzheimer's Disease : Jad. PMID 35431257 DOI: 10.3233/JAD-220211  0.338
2022 Whitehouse P, Gandy S, Saini V, George DR, Larson EB, Alexander GC, Avorn J, Brownlee S, Camp C, Chertkow H, Fugh-Berman A, Howard R, Kesselheim A, Langa K, Perry G, et al. Making the Case for Accelerated Withdrawal of Aducanumab. Journal of Alzheimer's Disease : Jad. PMID 35404287 DOI: 10.3233/JAD-220262  0.454
2022 Xolalpa-Cueva L, García-Carlos CA, Villaseñor-Zepeda R, Orta-Salazar E, Díaz-Cintra S, Peña-Ortega F, Perry G, Mondragón-Rodríguez S. Hyperphosphorylated Tau Relates to Improved Cognitive Performance and Reduced Hippocampal Excitability in the Young rTg4510 Mouse Model of Tauopathy. Journal of Alzheimer's Disease : Jad. PMID 35342085 DOI: 10.3233/JAD-215186  0.805
2022 Correia SC, Alves MG, Oliveira PF, Casadesus G, LaManna J, Perry G, Moreira PI. Hypoxic preconditioning averts sporadic Alzheimer's disease-like phenotype in rats: a focus on mitochondria. Antioxidants & Redox Signaling. PMID 35316086 DOI: 10.1089/ars.2019.8007  0.833
2022 Mirzayi P, Shobeiri P, Kalantari A, Perry G, Rezaei N. Optogenetics: implications for Alzheimer's disease research and therapy. Molecular Brain. 15: 20. PMID 35197102 DOI: 10.1186/s13041-022-00905-y  0.426
2022 Sena CM, Seiça R, Perry G. Editorial: Oxidative Stress Revisited-Major Role in Vascular Diseases, Volume II. Frontiers in Physiology. 12: 826129. PMID 35095578 DOI: 10.3389/fphys.2021.826129  0.313
2021 Wang Q, Davis PB, Qi X, Chen SG, Gurney ME, Perry G, Doraiswamy PM, Xu R. Gut-microbiota-microglia-brain interactions in Alzheimer's disease: knowledge-based, multi-dimensional characterization. Alzheimer's Research & Therapy. 13: 177. PMID 34670619 DOI: 10.1186/s13195-021-00917-1  0.493
2021 Wang L, Liu M, Gao J, Smith AM, Fujioka H, Liang J, Perry G, Wang X. Mitochondrial Fusion Suppresses Tau Pathology-Induced Neurodegeneration and Cognitive Decline. Journal of Alzheimer's Disease : Jad. PMID 34602490 DOI: 10.3233/JAD-215175  0.761
2021 Zheng C, Fillmore NR, Ramos-Cejudo J, Brophy M, Osorio R, Gurney ME, Qiu WQ, Au R, Perry G, Dubreuil M, Chen SG, Qi X, Davis PB, Do N, Xu R. Potential long-term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34569707 DOI: 10.1002/alz.12465  0.41
2021 Mahdiabadi S, Momtazmanesh S, Perry G, Rezaei N. Immune modulations and immunotherapies for Alzheimer's disease: a comprehensive review. Reviews in the Neurosciences. PMID 34506700 DOI: 10.1515/revneuro-2021-0092  0.394
2021 Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL, Cho M, Lannfelt L, Cummings JL, Vergallo A. The Amyloid-β Pathway in Alzheimer's Disease. Molecular Psychiatry. PMID 34456336 DOI: 10.1038/s41380-021-01249-0  0.401
2021 Wang C, Shao C, Zhang L, Siedlak SL, Meabon JS, Peskind ER, Lu Y, Wang W, Perry G, Cook DG, Zhu X. Oxidative Stress Signaling in Blast TBI-Induced Tau Phosphorylation. Antioxidants (Basel, Switzerland). 10. PMID 34203583 DOI: 10.3390/antiox10060955  0.742
2021 Everett J, Lermyte F, Brooks J, Tjendana-Tjhin V, Plascencia-Villa G, Hands-Portman I, Donnelly JM, Billimoria K, Perry G, Zhu X, Sadler PJ, O'Connor PB, Collingwood JF, Telling ND. Biogenic metallic elements in the human brain? Science Advances. 7. PMID 34108207 DOI: 10.1126/sciadv.abf6707  0.605
2021 Pappolla MA, Perry G, Fang X, Zagorski M, Sambamurti K, Poeggeler B. Indoles as essential mediators in the gut-brain axis. Their role in Alzheimer's disease. Neurobiology of Disease. 105403. PMID 34087380 DOI: 10.1016/j.nbd.2021.105403  0.661
2021 Hampel H, Nisticò R, Seyfried NT, Levey AI, Modeste E, Lemercier P, Baldacci F, Toschi N, Garaci F, Perry G, Emanuele E, Valenzuela PL, Lucía A, Urbani A, Sancesario GM, et al. Omics Sciences for Systems Biology in Alzheimer's Disease: State-of-the-Art of the Evidence. Ageing Research Reviews. 101346. PMID 33915266 DOI: 10.1016/j.arr.2021.101346  0.378
2021 Živković L, Bajić V, Čabarkapa-Pirković A, Dekanski D, Forbes-Hernández TY, Zlatković-Švenda M, Perry G, Spremo-Potparević B. Strawberry (Fragaria ananassa duch.) Alba extract attenuates DNA damage in lymphocytes of patients with Alzheimer's disease. Journal of Food Biochemistry. e13637. PMID 33547659 DOI: 10.1111/jfbc.13637  0.318
2021 Martín-Maestro P, Gargini R, García E, Perry G, Avila J, García-Escudero V. Corrigendum to "Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease". Oxidative Medicine and Cellular Longevity. 2021: 1643631. PMID 33510835 DOI: 10.1155/2021/1643631  0.32
2021 Martínez-Maldonado A, Ontiveros-Torres MÁ, Harrington CR, Montiel-Sosa JF, Prandiz RG, Bocanegra-López P, Sorsby-Vargas AM, Bravo-Muñoz M, Florán-Garduño B, Villanueva-Fierro I, Perry G, Garcés-Ramírez L, de la Cruz F, Martínez-Robles S, Pacheco-Herrero M, et al. Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration. Journal of Alzheimer's Disease : Jad. PMID 33459640 DOI: 10.3233/JAD-201139  0.37
2020 Mondragón-Rodríguez S, Ordaz B, Orta-Salazar E, Díaz-Cintra S, Peña-Ortega F, Perry G. Hippocampal Unicellular Recordings and Hippocampal-dependent Innate Behaviors in an Adolescent Mouse Model of Alzheimer's disease. Bio-Protocol. 10: e3529. PMID 33654753 DOI: 10.21769/BioProtoc.3529  0.787
2020 Nunomura A, Perry G. RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs. Oxidative Medicine and Cellular Longevity. 2020: 2638130. PMID 33312335 DOI: 10.1155/2020/2638130  0.668
2020 Avila J, Perry G. A multilevel view of the development of Alzheimer's Disease. Neuroscience. PMID 33246061 DOI: 10.1016/j.neuroscience.2020.11.015  0.431
2020 Forero DA, Lopez-Leon S, Perry G. A brief guide to the science and art of writing manuscripts in biomedicine. Journal of Translational Medicine. 18: 425. PMID 33167977 DOI: 10.1186/s12967-020-02596-2  0.51
2020 Kelley AR, Colley ME, Dyer S, Bach SBH, Zhu X, Perry G. Ethanol-fixed, paraffin-embedded tissue imaging: implications for Alzheimer's disease research. Journal of the American Society For Mass Spectrometry. PMID 32803969 DOI: 10.1021/Jasms.0C00195  0.618
2020 Plascencia-Villa G, Perry G. Status and future directions of clinical trials in Alzheimer's disease. International Review of Neurobiology. 154: 3-50. PMID 32739008 DOI: 10.1016/bs.irn.2020.03.022  0.354
2020 Perry G. Alzheimer's Disease Patients in the Crosshairs of COVID-19. Journal of Alzheimer's Disease : Jad. 76: 1. PMID 32623403 DOI: 10.3233/JAD-209004  0.348
2020 González-Sánchez M, Bartolome F, Antequera D, Puertas-Martín V, González P, Gómez-Grande A, Llamas-Velasco S, Herrero-San Martín A, Pérez-Martínez D, Villarejo-Galende A, Atienza M, Palomar-Bonet M, Cantero JL, Perry G, Orive G, et al. Decreased salivary lactoferrin levels are specific to Alzheimer's disease. Ebiomedicine. 102834. PMID 32586758 DOI: 10.1016/j.ebiom.2020.102834  0.397
2020 Reyes-Pablo AE, Campa-Córdoba BB, Luna-Viramontes NI, Ontiveros-Torres MÁ, Villanueva-Fierro I, Bravo-Muñoz M, Sáenz-Ibarra B, Barbosa O, Guadarrama-Ortíz P, Garcés-Ramírez L, de la Cruz F, Harrington CR, Martínez-Robles S, González-Ballesteros E, Perry G, et al. National Dementia BioBank: A Strategy for the Diagnosis and Study of Neurodegenerative Diseases in México. Journal of Alzheimer's Disease : Jad. PMID 32568191 DOI: 10.3233/Jad-191015  0.435
2020 Veurink G, Perry G, Singh SK. Role of antioxidants and a nutrient rich diet in Alzheimer's disease. Open Biology. 10: 200084. PMID 32543351 DOI: 10.1098/rsob.200084  0.413
2020 Hernandes-Alejandro M, Montaño S, Harrington CR, Wischik CM, Salas-Casas A, Cortes-Reynosa P, Pérez Salazar E, Cazares-Apatiga J, Apatiga-Perez R, Ontiveros Torres MÁ, Perry G, Pacheco-Herrero M, Luna-Muñoz J. Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32538846 DOI: 10.3233/JAD-200146  0.499
2020 Plascencia-Villa G, Perry G. Preventive and therapeutic strategies in Alzheimer's disease: focus on oxidative stress, redox metals and ferroptosis. Antioxidants & Redox Signaling. PMID 32486897 DOI: 10.1089/ars.2020.8134  0.544
2020 Wang W, Zhao F, Ma X, Perry G, Zhu X. Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances. Molecular Neurodegeneration. 15: 30. PMID 32471464 DOI: 10.1186/S13024-020-00376-6  0.759
2020 Obrenovich M, Jaworski H, Tadimalla T, Mistry A, Sykes L, Perry G, Bonomo RA. The Role of the Microbiota-Gut-Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases. Microorganisms. 8. PMID 32456229 DOI: 10.3390/microorganisms8050784  0.764
2020 Obrenovich M, Tabrez S, Siddiqui B, McCloskey B, Perry G. The Microbiota-Gut-Brain Axis-Heart Shunt Part II: Prosaic Foods and the Brain-Heart Connection in Alzheimer Disease. Microorganisms. 8. PMID 32244373 DOI: 10.3390/microorganisms8040493  0.753
2020 Reddy VP, Aryal P, Robinson S, Rafiu R, Obrenovich M, Perry G. Polyphenols in Alzheimer's Disease and in the Gut-Brain Axis. Microorganisms. 8. PMID 32023969 DOI: 10.3390/microorganisms8020199  0.787
2019 Gao J, Wang L, Gao C, Arakawa H, Perry G, Wang X. TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 165580. PMID 31678156 DOI: 10.1016/J.Bbadis.2019.165580  0.72
2019 Iverson GL, Gardner AJ, Shultz SR, Solomon GS, McCrory P, Zafonte R, Perry G, Hazrati LN, Keene CD, Castellani RJ. Chronic traumatic encephalopathy neuropathology might not be inexorably progressive or unique to repetitive neurotrauma. Brain : a Journal of Neurology. PMID 31670780 DOI: 10.1093/brain/awz286  0.552
2019 Montero-Odasso M, Perry G. Gait Disorders in Alzheimer's Disease and Other Dementias: There is Something in the Way You Walk. Journal of Alzheimer's Disease : Jad. PMID 31476163 DOI: 10.3233/JAD-190790  0.316
2019 Gao J, Wang L, Yan T, Perry G, Wang X. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration. Molecular and Cellular Neurosciences. 103396. PMID 31445085 DOI: 10.1016/J.Mcn.2019.103396  0.682
2019 Flores-Rodríguez P, Harrington CR, Wischik CM, Ibarra-Bracamontes V, Zarco N, Navarrete A, Martínez-Maldonado A, Guadarrama-Ortíz P, Villanueva-Fierro I, Ontiveros-Torres MA, Perry G, Alonso AD, Floran-Garduño B, Segovia J, Luna-Muñoz J. Phospho-Tau Protein Expression in the Cell Cycle of SH-SY5Y Neuroblastoma Cells: A Morphological Study. Journal of Alzheimer's Disease : Jad. PMID 31424392 DOI: 10.3233/Jad-190155  0.424
2019 Singh SK, Srivastav S, Castellani RJ, Plascencia-Villa G, Perry G. Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 31376068 DOI: 10.1007/S13311-019-00767-8  0.608
2019 Sena CM, Seiça R, Perry G. Editorial: Oxidative Stress Revisited-Major Role in Vascular Diseases. Frontiers in Physiology. 10: 788. PMID 31293452 DOI: 10.3389/fphys.2019.00788  0.457
2019 Hernández F, Cuadros R, Ollá I, García C, Ferrer I, Perry G, Avila J. Differences in structure and function between human and murine tau. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 1865: 2024-2030. PMID 31189515 DOI: 10.1016/j.bbadis.2018.08.010  0.422
2019 Liu M, Wang L, Gao J, Dong Q, Perry G, Ma X, Wang X. Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice. Journal of Alzheimer's Disease : Jad. PMID 31156179 DOI: 10.3233/Jad-190281  0.699
2019 Hampel H, Lista S, Mango D, Nisticò R, Perry G, Avila J, Hernandez F, Geerts H, Vergallo A. Lithium as a Treatment for Alzheimer's Disease: The Systems Pharmacology Perspective. Journal of Alzheimer's Disease : Jad. PMID 31156173 DOI: 10.3233/JAD-190197  0.398
2019 Jones L, Kumar J, Mistry A, Sankar Chittoor Mana T, Perry G, Reddy VP, Obrenovich M. The Transformative Possibilities of the Microbiota and Mycobiota for Health, Disease, Aging, and Technological Innovation. Biomedicines. 7. PMID 30925795 DOI: 10.3390/Biomedicines7020024  0.772
2019 Castellani RJ, Plascencia-Villa G, Perry G. The amyloid cascade and Alzheimer's disease therapeutics: theory versus observation. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 30760863 DOI: 10.1038/s41374-019-0231-z  0.493
2019 Espay AJ, Vizcarra JA, Marsili L, Lang AE, Simon DK, Merola A, Josephs KA, Fasano A, Morgante F, Savica R, Greenamyre JT, Cambi F, Yamasaki TR, Tanner CM, Gan-Or Z, ... ... Perry G, et al. Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology. 92: 329-337. PMID 30745444 DOI: 10.1212/Wnl.0000000000006926  0.35
2018 Castellani RJ, Perry G. Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges. Journal of Alzheimer's Disease : Jad. PMID 30584140 DOI: 10.3233/JAD-180721  0.457
2018 Sena CM, Leandro A, Azul L, Seiça R, Perry G. Vascular Oxidative Stress: Impact and Therapeutic Approaches. Frontiers in Physiology. 9: 1668. PMID 30564132 DOI: 10.3389/fphys.2018.01668  0.379
2018 Wang C, Zhao F, Shen K, Wang W, Siedlak SL, Lee HG, Phelix CF, Perry G, Shen L, Tang B, Yan R, Zhu X. The sterol regulatory element-binding protein 2 is likely dysregulated by tau alterations in Alzheimer disease. Brain Pathology (Zurich, Switzerland). PMID 30515907 DOI: 10.1111/Bpa.12691  0.838
2018 Kelley AR, Bach SBH, Perry G. Analysis of post-translational modifications in Alzheimer's disease by mass spectrometry. Biochimica Et Biophysica Acta. Molecular Basis of Disease. PMID 30481587 DOI: 10.1016/J.Bbadis.2018.11.002  0.483
2018 Pinho TS, Correia SC, Perry G, Ambrósio AF, Moreira PI. Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies. Biochimica Et Biophysica Acta. Molecular Basis of Disease. PMID 30412792 DOI: 10.1016/J.Bbadis.2018.10.037  0.776
2018 Peluso I, Palmery M, Yarla NS, Perry G, Kamal MA. From Oxidative Stress to Ageing via Lifestyle, Nutraceuticals, Polypharmacy, and Neuropsychological Factors. Oxidative Medicine and Cellular Longevity. 2018: 6352689. PMID 30363930 DOI: 10.1155/2018/6352689  0.308
2018 Vasquez V, Mitra J, Perry G, Rao KS, Hegde ML. An Inducible Alpha-Synuclein Expressing Neuronal Cell Line Model for Parkinson's Disease1. Journal of Alzheimer's Disease : Jad. PMID 30320583 DOI: 10.3233/JAD-180610  0.307
2018 Wang L, Gao J, Liu J, Siedlak SL, Torres S, Fujioka H, Huntley ML, Jiang Y, Ji H, Yan T, Harland M, Termsarasab P, Zeng S, Jiang Z, Liang J, ... Perry G, et al. Mitofusin 2 Regulates Axonal Transport of Calpastatin to Prevent Neuromuscular Synaptic Elimination in Skeletal Muscles. Cell Metabolism. PMID 30017354 DOI: 10.1016/J.Cmet.2018.06.011  0.751
2018 Perry G, Avila J, Moreira PI, Sorensen AA, Tabaton M. Preface. Journal of Alzheimer's Disease : Jad. PMID 29782320 DOI: 10.3233/JAD-179945  0.597
2018 Smith MA, Bowen RL, Nguyen RQ, Perry G, Atwood CS, Rimm AA. Putative Gonadotropin Releasing Hormone Agonist Therapy and Dementia: An Application of Medicare Hospitalization Claims Data. Journal of Alzheimer's Disease : Jad. PMID 29782310 DOI: 10.3233/Jad-170847  0.813
2018 Everett J, Collingwood JF, Tjendana-Tjhin V, Brooks J, Lermyte F, Plascencia-Villa G, Hands-Portman I, Dobson J, Perry G, Telling ND. Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects. Nanoscale. PMID 29688240 DOI: 10.1039/C7Nr06794A  0.445
2018 Mondragón Rodríguez S, Salas Gallardo A, Gonzalez Pereyra P, Macías M, Ordaz B, Peña Ortega F, Aguilar Vazquez A, Orta Salazar E, Díaz Cintra S, Perry G, Williams S. Phosphorylation of tau protein correlates with changes in hippocampal theta oscillations and reduces hippocampal excitability in Alzheimer's model. The Journal of Biological Chemistry. PMID 29632073 DOI: 10.1074/Jbc.Ra117.001187  0.47
2018 Paley EL, Perry G. Towards an Integrative Understanding of tRNA Aminoacylation-Diet-Host-Gut Microbiome Interactions in Neurodegeneration. Nutrients. 10. PMID 29587458 DOI: 10.3390/nu10040410  0.399
2018 Perry G, Avila J, Zhu X. Birth of JAD: 20 Years Later. Journal of Alzheimer's Disease : Jad. 62: 901. PMID 29562547 DOI: 10.3233/JAD-180120  0.546
2018 Yan T, Wang L, Gao J, Siedlak SL, Huntley ML, Termsarasab P, Perry G, Chen SG, Wang X. Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 29562525 DOI: 10.3233/Jad-180023  0.818
2018 Mohammadi A, Maleki-Jamshid A, Sanooghi D, Milan PB, Rahmani A, Sefat F, Shahpasand K, Soleimani M, Bakhtiari M, Belali R, Faghihi F, Joghataei MT, Perry G, Mozafari M. Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological Disorders. Molecular Neurobiology. PMID 29549645 DOI: 10.1007/s12035-018-0968-1  0.314
2018 Gao J, Wang L, Huntley ML, Perry G, Wang X. Pathomechanisms of TDP-43 in neurodegeneration. Journal of Neurochemistry. PMID 29486049 DOI: 10.1111/Jnc.14327  0.765
2018 Hampel H, Vergallo A, Aguilar LF, Benda N, Broich K, Cuello AC, Cummings J, Dubois B, Federoff HJ, Fiandaca M, Genthon R, Haberkamp M, Karran E, Mapstone M, Perry G, et al. Precision pharmacology for Alzheimer's disease. Pharmacological Research. PMID 29458203 DOI: 10.1016/J.Phrs.2018.02.014  0.401
2018 Reale M, D'Angelo C, Costantini E, Di Nicola M, Yarla NS, Kamal MA, Salvador N, Perry G. Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology. Journal of Alzheimer's Disease : Jad. 62: 467-476. PMID 29439355 DOI: 10.3233/JAD-170999  0.478
2018 Jiang S, Nandy P, Wang W, Ma X, Hsia J, Wang C, Wang Z, Niu M, Siedlak SL, Torres S, Fujioka H, Xu Y, Lee HG, Perry G, Liu J, et al. Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex. Molecular Neurodegeneration. 13: 5. PMID 29391029 DOI: 10.1186/S13024-018-0238-8  0.829
2018 Plascencia-Villa G, Perry G. Iron·ic facts about dementia. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 29353235 DOI: 10.1136/jnnp-2017-317164  0.45
2018 Kelley AR, Perry G, Bach SBH. Characterization of Proteins Present in Isolated Senile Plaques from Alzheimer's Diseased Brains by MALDI-TOF MS with MS/MS. Acs Chemical Neuroscience. PMID 29301075 DOI: 10.1021/Acschemneuro.7B00445  0.393
2017 Henderson LE, Abdelmegeed MA, Yoo SH, Rhee SG, Zhu X, Smith MA, Nguyen RQ, Perry G, Song BJ. Enhanced Phosphorylation of Bax and Its Translocation into Mitochondria in the Brains of Individuals Affiliated with Alzheimer's Disease. The Open Neurology Journal. 11: 48-58. PMID 29290835 DOI: 10.2174/1874205X01711010048  0.812
2017 Zabel M, Nackenoff A, Kirsch WM, Harrison F, Perry G, Schrag M. Markers of oxidative damage to lipids, nucleic acids and proteins and antioxidant enzymes activities in Alzheimer's disease brain: a meta-analysis in human pathological specimens. Free Radical Biology & Medicine. PMID 29253591 DOI: 10.1016/J.Freeradbiomed.2017.12.016  0.437
2017 Rodriguez RA, Chen LY, Plascencia-Villa G, Perry G. Thermodynamics of amyloid-β fibril elongation: atomistic details of the transition state. Acs Chemical Neuroscience. PMID 29239603 DOI: 10.1021/acschemneuro.7b00409  0.377
2017 Martín-Maestro P, Gargini R, García E, Perry G, Avila J, García-Escudero V. Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease. Oxidative Medicine and Cellular Longevity. 2017: 9302761. PMID 29201274 DOI: 10.1155/2017/9302761  0.437
2017 Kelley AR, Colley ME, Perry G, Bach SBH. Incubation with Cu(II) and Zn(II) salts enhances MALDI-TOF mass spectra of amyloid-beta and α-synuclein toward in-vivo analysis. Journal of Mass Spectrometry : Jms. PMID 29111606 DOI: 10.1002/Jms.4044  0.38
2017 Iverson GL, Keene CD, Perry G, Castellani RJ. The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features. Journal of Alzheimer's Disease : Jad. PMID 29103039 DOI: 10.3233/JAD-170654  0.562
2017 Castellani RJ, Perry G. Dementia Pugilistica Revisited. Journal of Alzheimer's Disease : Jad. 60: 1209-1221. PMID 29036831 DOI: 10.3233/JAD-170669  0.415
2017 Wang W, Yin J, Ma X, Zhao F, Siedlak SL, Wang Z, Fujioka H, Xu Y, Perry G, Zhu X. Inhibition of mitochondrial fragmentation protects against Alzheimer's disease in rodent model. Human Molecular Genetics. PMID 28973308 DOI: 10.1093/Hmg/Ddx299  0.813
2017 Barh D, García-Solano ME, Tiwari S, Bhattacharya A, Jain N, Torres-Moreno D, Ferri B, Silva A, Azevedo V, Ghosh P, Blum K, Conesa-Zamora P, Perry G. BARHL1 Is Downregulated in Alzheimer's Disease and May Regulate Cognitive Functions through ESR1 and Multiple Pathways. Genes. 8. PMID 28956815 DOI: 10.3390/Genes8100245  0.334
2017 Manyevitch R, Protas M, Scarpiello S, Deliso M, Bass B, Nanajian A, Chang M, Thompson SM, Khoury N, Gonnella R, Trotz M, Moore DB, Harms E, Perry G, Clunes L, et al. Evaluation Of Metabolic And Synaptic Dysfunction Hypotheses Of Alzheimer's Disease (Ad): A Meta-Analysis Of Csf Markers. Current Alzheimer Research. PMID 28933272 DOI: 10.2174/1567205014666170921122458  0.471
2017 Nunomura A, Lee HG, Zhu X, Perry G. Consequences of RNA oxidation on protein synthesis rate and fidelity: implications for the pathophysiology of neuropsychiatric disorders. Biochemical Society Transactions. PMID 28778984 DOI: 10.1042/BST20160433  0.793
2017 Putta S, Yarla NS, Peluso I, Tiwari DK, Reddy GV, Giri PV, Kumar N, Malla R, Chari VB, Reddy D RS, Bade R, Mannarapu M, Barretto G, Lu DY, Tarasov VV, ... ... Perry G, et al. Anthocyanins: Possible role as Multitarget therapeutic agents for prevention and therapy of chronic diseases. Current Pharmaceutical Design. PMID 28741457 DOI: 10.2174/1381612823666170519151801  0.6
2017 Cornejo A, Aguilar Sandoval F, Caballero L, Machuca L, Muñoz P, Caballero J, Perry G, Ardiles A, Areche C, Melo F. Rosmarinic acid prevents fibrillization and diminishes vibrational modes associated to β sheet in tau protein linked to Alzheimer's disease. Journal of Enzyme Inhibition and Medicinal Chemistry. 32: 945-953. PMID 28701064 DOI: 10.1080/14756366.2017.1347783  0.386
2017 Khalsa DS, Perry G. The Four Pillars of Alzheimer's Prevention. Cerebrum : the Dana Forum On Brain Science. 2017. PMID 28698774  0.322
2017 Hajipour MJ, Santoso MR, Rezaee F, Aghaverdi H, Mahmoudi M, Perry G. Advances in Alzheimer's Diagnosis and Therapy: The Implications of Nanotechnology. Trends in Biotechnology. PMID 28666544 DOI: 10.1016/j.tibtech.2017.06.002  0.448
2017 Siedlak SL, Jiang Y, Huntley ML, Wang L, Gao J, Xie F, Liu J, Su B, Perry G, Wang X. TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 28527219 DOI: 10.3233/Jad-170190  0.817
2017 Rodriguez RA, Chen LY, Plascencia-Villa G, Perry G. Elongation affinity, activation barrier, and stability of Aβ42 oligomers/fibrils in physiological saline. Biochemical and Biophysical Research Communications. PMID 28427941 DOI: 10.1016/j.bbrc.2017.04.084  0.38
2017 Doens D, Valiente PA, Mfuh AM, X T Vo A, Tristan A, Carreño L, Quijada M, Nguyen VT, Perry G, Larionov OV, Lleonart R, L Fernandez P. Identification of inhibitors of CD36-Amyloid beta binding as potential agents for Alzheimer's disease. Acs Chemical Neuroscience. PMID 28150942 DOI: 10.1021/Acschemneuro.6B00386  0.359
2017 Bourdon AK, Villareal G, Perry G, Phelix CF. Alzheimer's and Parkinson's Disease Novel Therapeutic Target International Journal of Knowledge Discovery in Bioinformatics. 7: 68-82. DOI: 10.4018/IJKDB.2017070104  0.397
2017 Phelix CF, Bourdon AK, Dugan JL, Villareal G, Perry G. MSDC-0160 and MSDC-0602 Binding with Human Mitochondrial Pyruvate Carrier (MPC) 1 and 2 Heterodimer International Journal of Knowledge Discovery in Bioinformatics. 7: 43-67. DOI: 10.4018/IJKDB.2017070103  0.303
2017 Bass B, Scarpiello S, Manyevitch R, Protas M, Nanajian A, Chang M, Thompson S, Khoury N, Deliso M, Perry G, Trotz M, Moore DB, Friederich J, Nuguri V, Murray IV. [P2-230]: USING CSF MARKERS TO VALIDATE METABOLIC AND SYNAPTIC DYSFUNCTION HYPOTHESES OF ALZHEIMER's DISEASE (AD): META-ANALYSIS Alzheimer's & Dementia. 13: P699-P699. DOI: 10.1016/J.Jalz.2017.06.882  0.729
2016 Forero DA, Prada CF, Perry G. Functional and Genomic Features of Human Genes Mutated in Neuropsychiatric Disorders. The Open Neurology Journal. 10: 143-148. PMID 27990183 DOI: 10.2174/1874205X01610010143  0.561
2016 Kelley AR, Perry G, Bethea C, Castellani RJ, Bach SB. Molecular Mapping Alzheimer's Disease: MALDI Imaging of Formalin-fixed, Paraffin-embedded Human Hippocampal Tissue. The Open Neurology Journal. 10: 88-98. PMID 27843502 DOI: 10.2174/1874205X01610010088  0.587
2016 Nunomura A, Zhu X, Perry G. Modulation of Parkinson's Disease Associated Protein Rescues Alzheimer's Disease Degeneration. Journal of Alzheimer's Disease : Jad. PMID 27802241 DOI: 10.3233/JAD-160878  0.832
2016 Rueli RH, Torres DJ, Dewing AS, Kiyohara AC, Barayuga SM, Bellinger MT, Uyehara-Lock JH, White LR, Moreira PI, Berry MJ, Perry G, Bellinger FP. Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology. Journal of Alzheimer's Disease : Jad. PMID 27802219 DOI: 10.3233/JAD-151208  0.639
2016 Perry G. Promise from the Sea. Marine Drugs. 14. PMID 27735831 DOI: 10.3390/md14100178  0.388
2016 Aryan N, Betts-Obregon BS, Perry G, Tsin AT. Oxidative Stress Induces Senescence in Cultured RPE Cells. The Open Neurology Journal. 10: 83-7. PMID 27651846 DOI: 10.2174/1874205X01610010083  0.313
2016 Mondragón-Rodríguez S, Perry G, Peña-Ortega F, Williams S. Tau, Amyloid beta and Deep brain stimulation: Aiming to restore cognitive deficit in Alzheimer's disease. Current Alzheimer Research. PMID 27539594 DOI: 10.2174/1567205013666160819131336  0.851
2016 Correia SC, Perry G, Moreira PI. Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks. Biochimica Et Biophysica Acta. PMID 27460705 DOI: 10.1016/J.Bbadis.2016.07.010  0.766
2016 Manassero G, Guglielmotto M, Zamfir R, Borghi R, Colombo L, Salmona M, Perry G, Odetti P, Arancio O, Tamagno E, Tabaton M. Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein. Aging Cell. PMID 27406053 DOI: 10.1111/Acel.12500  0.634
2016 Hofer T, Perry G. Nucleic acid oxidative damage in Alzheimer's disease-explained by the hepcidin-ferroportin neuronal iron overload hypothesis? Journal of Trace Elements in Medicine and Biology : Organ of the Society For Minerals and Trace Elements (Gms). PMID 27329321 DOI: 10.1016/j.jtemb.2016.06.005  0.527
2016 Pistollato F, Ohayon EL, Lam A, Langley GR, Novak TJ, Pamies D, Perry G, Trushina E, Williams RS, Roher AE, Hartung T, Harnad S, Barnard N, Morris MC, Lai MC, et al. Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities. Oncotarget. PMID 27229915 DOI: 10.18632/Oncotarget.9175  0.363
2016 Plascencia-Villa G, Ponce A, Collingwood JF, Arellano-Jiménez MJ, Zhu X, Rogers JT, Betancourt I, José-Yacamán M, Perry G. High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer's disease. Scientific Reports. 6: 24873. PMID 27121137 DOI: 10.1038/Srep24873  0.644
2016 Forero DA, González-Giraldo Y, López-Quintero C, Castro-Vega LJ, Barreto GE, Perry G. Meta-analysis of Telomere Length in Alzheimer's Disease. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 27091133 DOI: 10.1093/Gerona/Glw053  0.703
2016 Singh SK, Srivastav S, Yadav AK, Srikrishna S, Perry G. Overview of Alzheimer's Disease and Some Therapeutic Approaches Targeting Aβ by Using Several Synthetic and Herbal Compounds. Oxidative Medicine and Cellular Longevity. 2016: 7361613. PMID 27034741 DOI: 10.1155/2016/7361613  0.489
2016 Ontiveros-Torres MÁ, Labra-Barrios ML, Díaz-Cintra S, Aguilar-Vázquez AR, Moreno-Campuzano S, Flores-Rodríguez P, Luna-Herrera C, Mena R, Perry G, Florán-Garduño B, Luna-Muñoz J, Luna-Arias JP. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse. Journal of Alzheimer's Disease : Jad. 52: 243-69. PMID 27031470 DOI: 10.3233/Jad-150837  0.482
2016 Itzhaki RF, Lathe R, Balin BJ, Ball MJ, Bearer EL, Braak H, Bullido MJ, Carter C, Clerici M, Cosby SL, Del Tredici K, Field H, Fulop T, Grassi C, Griffin WS, ... ... Perry G, et al. Microbes and Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 26967229 DOI: 10.3233/Jad-160152  0.384
2016 Wang C, Zhang F, Jiang S, Siedlak SL, Shen L, Perry G, Wang X, Tang B, Zhu X. Estrogen receptor-α is localized to neurofibrillary tangles in Alzheimer's disease. Scientific Reports. 6: 20352. PMID 26837465 DOI: 10.1038/Srep20352  0.845
2016 Calderón-Garcidueñas L, Reynoso-Robles R, Vargas-Martínez J, Gómez-Maqueo-Chew A, Pérez-Guillé B, Mukherjee PS, Torres-Jardón R, Perry G, Gónzalez-Maciel A. Prefrontal white matter pathology in air pollution exposed Mexico City young urbanites and their potential impact on neurovascular unit dysfunction and the development of Alzheimer's disease. Environmental Research. 146: 404-417. PMID 26829765 DOI: 10.1016/J.Envres.2015.12.031  0.374
2016 Forero DA, González-Giraldo Y, López-Quintero C, Castro-Vega LJ, Barreto GE, Perry G. Telomere length in Parkinson's disease: A meta-analysis. Experimental Gerontology. 75: 53-5. PMID 26772888 DOI: 10.1016/J.Exger.2016.01.002  0.576
2016 Forero DA, Wonkam A, Wang W, Laissue P, López-Correa C, Fernández-López JC, Mugasimangalam R, Perry G. Current needs for human and medical genomics research infrastructure in low and middle income countries. Journal of Medical Genetics. PMID 26740506 DOI: 10.1136/Jmedgenet-2015-103631  0.567
2016 Martín-Maestro P, Gargini R, Perry G, Avila J, García-Escudero V. PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer's disease. Human Molecular Genetics. 25: 792-806. PMID 26721933 DOI: 10.1093/hmg/ddv616  0.449
2016 Forero DA, González-Giraldo Y, López-Quintero C, Castro-Vega LJ, Barreto GE, Perry G. Telomere length in Parkinson's disease: A meta-analysis Experimental Gerontology. 75: 53-55. DOI: 10.1016/j.exger.2016.01.002  0.612
2016 Singh SK, Castellani R, Perry G. [Oxidative stress and Alzheimer's disease]. Acta Physiologica Sinica. 64: 189-198. DOI: 10.1007/978-3-319-33486-8_10  0.462
2015 Kelley AR, Perry G, Castellani RJ, Bach SB. Laser-Induced In-Source Decay Applied to the Determination of Amyloid-Beta in Alzheimer's Brains. Acs Chemical Neuroscience. PMID 26720297 DOI: 10.1021/Acschemneuro.5B00295  0.597
2015 Sharoar MG, Shi Q, Ge Y, He W, Hu X, Perry G, Zhu X, Yan R. Dysfunctional tubular endoplasmic reticulum constitutes a pathological feature of Alzheimer's disease. Molecular Psychiatry. PMID 26619807 DOI: 10.1038/Mp.2015.181  0.706
2015 Zivkovic L, Bajic V, Perry G, Spremo-Potparevica B. Alterations of the X Chromosome in Lymphocytes of Alzheimer's Disease Patients. Current Alzheimer Research. PMID 26502819 DOI: 10.2174/1567205012666151027124154  0.415
2015 Jiang Z, Wang W, Perry G, Zhu X, Wang X. Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis. Translational Neurodegeneration. 4: 14. PMID 26225210 DOI: 10.1186/S40035-015-0037-X  0.776
2015 Zhang F, Wang W, Siedlak SL, Liu Y, Liu J, Jiang K, Perry G, Zhu X, Wang X. Miro1 deficiency in amyotrophic lateral sclerosis. Frontiers in Aging Neuroscience. 7: 100. PMID 26074815 DOI: 10.3389/Fnagi.2015.00100  0.78
2015 Calderón-Garcidueñas L, Franco-Lira M, D'Angiulli A, Rodríguez-Díaz J, Blaurock-Busch E, Busch Y, Chao CK, Thompson C, Mukherjee PS, Torres-Jardón R, Perry G. Mexico City normal weight children exposed to high concentrations of ambient PM2.5 show high blood leptin and endothelin-1, vitamin D deficiency, and food reward hormone dysregulation versus low pollution controls. Relevance for obesity and Alzheimer disease. Environmental Research. 140: 579-92. PMID 26037109 DOI: 10.1016/J.Envres.2015.05.012  0.308
2015 Zhang F, Su B, Wang C, Siedlak SL, Mondragon-Rodriguez S, Lee HG, Wang X, Perry G, Zhu X. Posttranslational modifications of α-tubulin in alzheimer disease. Translational Neurodegeneration. 4: 9. PMID 26029362 DOI: 10.1186/S40035-015-0030-4  0.836
2015 Avila J, Perry G, Strange BA, Hernandez F. Alternative neural circuitry that might be impaired in the development of Alzheimer disease. Frontiers in Neuroscience. 9: 145. PMID 25954151 DOI: 10.3389/fnins.2015.00145  0.356
2015 Castellani RJ, Perry G, Iverson GL. Chronic effects of mild neurotrauma: putting the cart before the horse? Journal of Neuropathology and Experimental Neurology. 74: 493-9. PMID 25933385 DOI: 10.1097/NEN.0000000000000193  0.6
2015 Pelcovits A, Marriotti R, Heath J, Perry G, Castellani RJ. Simultaneous onset of Alzheimer's disease in a husband and wife in their mid-fifties: what do we really know about environmental factors? The Open Neurology Journal. 9: 1-3. PMID 25932054 DOI: 10.2174/1874205X01509010001  0.661
2015 Gerenu G, Liu K, Chojnacki JE, Saathoff JM, Martínez-Martín P, Perry G, Zhu X, Lee HG, Zhang S. Curcumin/Melatonin Hybrid 5-(4-Hydroxy-phenyl)-3-oxo-pentanoic Acid [2-(5-Methoxy-1H-indol-3-yl)-ethyl]-amide Ameliorates AD-Like Pathology in the APP/PS1 Mouse Model. Acs Chemical Neuroscience. PMID 25893520 DOI: 10.1021/acschemneuro.5b00082  0.771
2015 Petersen RB, Lissemore FM, Appleby B, Aggarwal N, Boyatzis R, Casadesus G, Cummings J, Jack A, Perry G, Safar J, Sajatovic M, Surewicz W, Wang Y, Whitehouse P, Lerner A. From Neurodegeneration to Brain Health: An Integrated Approach. Journal of Alzheimer's Disease : Jad. PMID 25720413 DOI: 10.3233/Jad-150043  0.737
2015 Carvalho C, Correia SC, Perry G, Castellani RJ, Moreira PI. Cerebrovascular and mitochondrial abnormalities in Alzheimer's disease: a brief overview. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 25608860 DOI: 10.1007/S00702-015-1367-7  0.816
2015 Bowen RL, Perry G, Xiong C, Smith MA, Atwood CS. A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks. Journal of Alzheimer's Disease : Jad. 44: 549-60. PMID 25310993 DOI: 10.3233/Jad-141626  0.753
2015 A. Perry E, Perry G. Cellular Pathology of Alzheimer Disease Cell & Developmental Biology. 4. DOI: 10.4172/2168-9296.1000E134  0.528
2015 Hammack CD, Perry G, LeBaron RG, Villareal G, Phelix CF. Low Dose Pioglitazone Attenuates Oxidative Damage in Early Alzheimer's Disease by Binding mitoNEET International Journal of Knowledge Discovery in Bioinformatics. 5: 24-45. DOI: 10.4018/Ijkdb.2015010103  0.499
2015 Avila J, Perry G, Strange BA, Hernandez F. Alternative neural circuitry that might be impaired in the development of Alzheimer disease Frontiers in Neuroscience. 9. DOI: 10.3389/fnins.2015.00145  0.33
2015 Perry G, Perry EA, Moreira PI, Correia SS, Castellani RJ, Wang X, Lee H, Zhu X. P3-029: Oxidative damage is correlated with mitochondrial autophagy Alzheimer's & Dementia. 11: P630-P630. DOI: 10.1016/J.Jalz.2015.06.895  0.794
2015 Perry G, Kelley AR, Bach S, Castellani RJ. P2-152: Molecular mapping of Alzheimer's disease: Imaging mass spectrometry Alzheimer's & Dementia. 11: P545-P545. DOI: 10.1016/J.Jalz.2015.06.691  0.586
2015 Phelix CF, Perry G, McHardy SF. P3-320: Molecular docking analysis of mitochondrial pyruvate carrier (MPC) 1 and 2 with pyruvate and inhibitors: Thiazolidinediones currently in clinical trials to delay mild cognitive impairment and Alzheimer's disease Alzheimer's & Dementia. 11: P760-P761. DOI: 10.1016/j.jalz.2015.06.1694  0.37
2015 Correia SC, Moreira PI, Perry G. Autophagy in alzheimer’s disease: A cleaning service out-of-order? Toxicity and Autophagy in Neurodegenerative Disorders. 123-142. DOI: 10.1007/978-3-319-13939-5_7  0.795
2015 Pelcovits A, Marriotti R, Heath J, Perry G, Castellani RJ. Simultaneous Onset of Alzheimer’s Disease in a Husband and Wife in their Mid-Fifties: What do we Really know about Environmental Factors? Open Neurology Journal. 9: 1-3.  0.538
2014 Fornicola W, Pelcovits A, Li BX, Heath J, Perry G, Castellani RJ. Alzheimer Disease Pathology in Middle Age Reveals a Spatial-Temporal Disconnect Between Amyloid-β and Phosphorylated Tau. The Open Neurology Journal. 8: 22-6. PMID 25628768 DOI: 10.2174/1874205X01408010022  0.669
2014 Forero DA, Vélez-van-Meerbeke A, Deshpande SN, Nicolini H, Perry G. Neuropsychiatric genetics in developing countries: Current challenges. World Journal of Psychiatry. 4: 69-71. PMID 25540721 DOI: 10.5498/Wjp.V4.I4.69  0.569
2014 Fawver JN, Ghiwot Y, Koola C, Carrera W, Rodriguez-Rivera J, Hernandez C, Dineley KT, Kong Y, Li J, Jhamandas J, Perry G, Murray IV. Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease. Current Alzheimer Research. 11: 928-40. PMID 25387341 DOI: 10.2174/1567205011666141107124538  0.74
2014 Xia J, Rocke DM, Perry G, Ray M. Differential network analyses of Alzheimer's disease identify early events in Alzheimer's disease pathology. International Journal of Alzheimer's Disease. 2014: 721453. PMID 25147748 DOI: 10.1155/2014/721453  0.464
2014 Rodrigues R, Petersen RB, Perry G. Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability. Cellular and Molecular Neurobiology. 34: 925-49. PMID 24927694 DOI: 10.1007/S10571-014-0074-5  0.649
2014 Brinkley WR, Perry G. Lester (Skip) Binder (1949-2013): in the beginning was tau. Journal of Alzheimer's Disease : Jad. 40: S5. PMID 24867914 DOI: 10.3233/JAD-140877  0.748
2014 Bonda DJ, Wang X, Lee HG, Smith MA, Perry G, Zhu X. Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass. Neuroscience Bulletin. 30: 243-52. PMID 24733654 DOI: 10.1007/S12264-013-1424-X  0.86
2014 Blair JA, Siedlak SL, Wolfram JA, Nunomura A, Castellani RJ, Ferreira ST, Klein WL, Wang Y, Casadesus G, Smith MA, Perry G, Zhu X, Lee HG. Accumulation of intraneuronal amyloid-β is common in normal brain. Current Alzheimer Research. 11: 317-24. PMID 24597504 DOI: 10.2174/1567205011666140302200902  0.84
2014 Perry G, Castellani R. Plaques and tangles: Birthmarks of the aging soul Biochemical Pharmacology. 88: 423-425. PMID 24486570 DOI: 10.1016/j.bcp.2014.01.028  0.547
2014 Castellani RJ, Perry G. The complexities of the pathology-pathogenesis relationship in Alzheimer disease. Biochemical Pharmacology. 88: 671-6. PMID 24447936 DOI: 10.1016/j.bcp.2014.01.009  0.652
2014 Johnston JM, Hu WT, Fardo DW, Greco SJ, Perry G, Montine TJ, Trojanowski JQ, Shaw LM, Ashford JW, Tezapsidis N. Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential. Current Alzheimer Research. 11: 165-74. PMID 24359504 DOI: 10.2174/1567205010666131212114156  0.375
2014 Wang X, Wang W, Li L, Perry G, Lee HG, Zhu X. Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. Biochimica Et Biophysica Acta. 1842: 1240-7. PMID 24189435 DOI: 10.1016/J.Bbadis.2013.10.015  0.858
2014 Mondragón-Rodríguez S, Perry G, Luna-Muñoz J, Acevedo-Aquino MC, Williams S. Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome. Neuropathology and Applied Neurobiology. 40: 121-35. PMID 24033439 DOI: 10.1111/Nan.12084  0.42
2014 Bonda DJ, Stone JG, Torres SL, Siedlak SL, Perry G, Kryscio R, Jicha G, Casadesus G, Smith MA, Zhu X, Lee HG. Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance. Journal of Neurochemistry. 128: 162-72. PMID 23895348 DOI: 10.1111/Jnc.12380  0.832
2014 Perry E, Castellani R, Perry G. A New Outlook for Alzheimer’s Disease Atlas Journal of Medical and Biological Sciences. 1: 21-22. DOI: 10.5147/Ajmbs.2014.0200  0.77
2014 Mohorovic L, Lavezzi AM, Stifter S, Perry G, Malatestinic D, Micovic V, Materljan E, Haller H, Petrovic O. Methemoglobinemia—A biomarker and a link to ferric iron accumulation in Alzheimer’s disease Advances in Bioscience and Biotechnology. 5: 12-18. DOI: 10.4236/ABB.2014.51003  0.45
2014 Perry G. Looking at Alzheimer's disease from a different angle Future Neurology. 9: 19-22. DOI: 10.2217/fnl.13.68  0.368
2014 Fornicola W, Pelcovits A, Li BX, Heath J, Perry G, Castellani RJ. Alzheimer Disease Pathology in Middle Age Reveals a Spatial-Temporal Disconnect Between Amyloid-β and Phosphorylated Tau Open Neurology Journal. 8: 22-26. DOI: 10.2174/1874082001509010001  0.634
2014 Castellani RJ, Zhu X, Perry G, Moreira PI. Alzheimer's Disease: An Overview Reference Module in Biomedical Research. DOI: 10.1016/B978-0-12-801238-3.04491-3  0.812
2014 Castellani RJ, Moreira PI, Zhu X, Perry G. Alzheimer's Disease: Pathology and Pathogenesis Reference Module in Biomedical Research. DOI: 10.1016/B978-0-12-801238-3.00160-4  0.743
2014 Fawver JN, Ghiwot Y, Koola C, Carrera W, Rodriguez-Rivera J, Hernandez C, Dineley KT, Kong Y, Li J, Jhamandas J, Perry G, Murray IVJ. Islet amyloid polypeptide (iapp): A second amyloid in alzheimer’s disease Current Alzheimer Research. 11: 928-940.  0.362
2013 Bharadwaj PR, Bates KA, Porter T, Teimouri E, Perry G, Steele JW, Gandy S, Groth D, Martins RN, Verdile G. Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases. Translational Psychiatry. 3: e332. PMID 24301650 DOI: 10.1038/Tp.2013.97  0.462
2013 Fujioka H, Phelix CF, Friedland RP, Zhu X, Perry EA, Castellani RJ, Perry G. Apolipoprotein E4 prevents growth of malaria at the intraerythrocyte stage: implications for differences in racial susceptibility to Alzheimer's disease. Journal of Health Care For the Poor and Underserved. 24: 70-8. PMID 24241262 DOI: 10.1353/Hpu.2014.0009  0.81
2013 Jarero-Basulto JJ, Luna-Muñoz J, Mena R, Kristofikova Z, Ripova D, Perry G, Binder LI, Garcia-Sierra F. Proteolytic cleavage of polymeric tau protein by caspase-3: implications for Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 72: 1145-61. PMID 24226268 DOI: 10.1097/Nen.0000000000000013  0.792
2013 Williams WM, Torres S, Siedlak SL, Castellani RJ, Perry G, Smith MA, Zhu X. Antimicrobial peptide β-defensin-1 expression is upregulated in Alzheimer's brain. Journal of Neuroinflammation. 10: 127. PMID 24139179 DOI: 10.1186/1742-2094-10-127  0.826
2013 Paley EL, Perry G, Sokolova O. Tryptamine induces axonopathy and mitochondriopathy mimicking neurodegenerative diseases via tryptophanyl-tRNA deficiency. Current Alzheimer Research. 10: 987-1004. PMID 24117115 DOI: 10.2174/15672050113106660164  0.372
2013 Correia SC, Perry G, Castellani R, Moreira PI. Is exercise-in-a-bottle likely to proffer new insights into Alzheimer's disease? Journal of Neurochemistry. 127: 4-6. PMID 24074055 DOI: 10.1111/Jnc.12406  0.756
2013 Mondragón-Rodríguez S, Perry G, Zhu X, Moreira PI, Acevedo-Aquino MC, Williams S. Phosphorylation of tau protein as the link between oxidative stress, mitochondrial dysfunction, and connectivity failure: implications for Alzheimer's disease. Oxidative Medicine and Cellular Longevity. 2013: 940603. PMID 23936615 DOI: 10.1155/2013/940603  0.804
2013 Schrag M, Mueller C, Zabel M, Crofton A, Kirsch WM, Ghribi O, Squitti R, Perry G. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis. Neurobiology of Disease. 59: 100-10. PMID 23867235 DOI: 10.1016/J.Nbd.2013.07.005  0.441
2013 García-Escudero V, Martín-Maestro P, Perry G, Avila J. Deconstructing mitochondrial dysfunction in Alzheimer disease. Oxidative Medicine and Cellular Longevity. 2013: 162152. PMID 23840916 DOI: 10.1155/2013/162152  0.488
2013 Hou L, Lee HG, Han F, Tedesco JM, Perry G, Smith MA, Zagorski MG. Modification of amyloid-β1-42 fibril structure by methionine-35 oxidation. Journal of Alzheimer's Disease : Jad. 37: 9-18. PMID 23719512 DOI: 10.3233/Jad-122389  0.763
2013 Perry EA, Castellani RJ, Moreira PI, Nunomura A, Lui Q, Harris PL, Sayre LM, Szweda PA, Szweda LI, Zhu X, Smith MA, Perry G. Neurofilaments are the major neuronal target of hydroxynonenal-mediated protein cross-links. Free Radical Research. 47: 507-10. PMID 23566300 DOI: 10.3109/10715762.2013.794265  0.812
2013 Durán-González J, Michi ED, Elorza B, Perez-Córdova MG, Pacheco-Otalora LF, Touhami A, Paulson P, Perry G, Murray IV, Colom LV. Amyloid β peptides modify the expression of antioxidant repair enzymes and a potassium channel in the septohippocampal system. Neurobiology of Aging. 34: 2071-6. PMID 23473707 DOI: 10.1016/j.neurobiolaging.2013.02.005  0.722
2013 Zivković L, Spremo-Potparević B, Siedlak SL, Perry G, PlećaÅ¡-Solarović B, Milićević Z, Bajić VP. DNA damage in Alzheimer disease lymphocytes and its relation to premature centromere division. Neuro-Degenerative Diseases. 12: 156-63. PMID 23406622 DOI: 10.1159/000346114  0.63
2013 Perry G, Zhu X, Smith MA, Sorensen A, Avila J. Preface. Alzheimer's disease: advances for a new century. Journal of Alzheimer's Disease : Jad. 33: S1. PMID 23397602  0.77
2013 Haldar S, Beveridge 'J, Wong J, Singh A, Galimberti D, Borroni B, Zhu X, Blevins J, Greenlee J, Perry G, Mukhopadhyay CK, Schmotzer C, Singh N. A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD. Antioxidants & Redox Signaling. 19: 1662-75. PMID 23379482 DOI: 10.1089/Ars.2012.5032  0.669
2013 Colom LV, Perry G, Kuljis RO. Tackling the elusive challenges relevant to conquering the 100-plus year old problem of Alzheimer's disease. Current Alzheimer Research. 10: 108-16. PMID 23368433 DOI: 10.2174/1567205011310010015  0.417
2013 Santos RX, Correia SC, Zhu X, Smith MA, Moreira PI, Castellani RJ, Nunomura A, Perry G. Mitochondrial DNA oxidative damage and repair in aging and Alzheimer's disease. Antioxidants & Redox Signaling. 18: 2444-57. PMID 23216311 DOI: 10.1089/Ars.2012.5039  0.836
2013 Correia SC, Santos RX, Santos MS, Casadesus G, Lamanna JC, Perry G, Smith MA, Moreira PI. Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer's disease. Current Alzheimer Research. 10: 406-19. PMID 23061885 DOI: 10.2174/1567205011310040006  0.806
2013 Zhu X, Perry G, Smith MA, Wang X. Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 33: S253-62. PMID 22531428 DOI: 10.3233/Jad-2012-129005  0.836
2013 Castellani R, Perry G. Molecular Pathology of Alzheimer's Disease Colloquium Series On Neurobiology of Alzheimer's Disease. 1: 1-91. DOI: 10.4199/c00095ed1v01y201310alz001  0.381
2013 Perry G, Zhu X, Smith MA, Sorensen A, Avila J. Alzheimer's disease: Advances for a new century Journal of Alzheimer's Disease. 33: S1. DOI: 10.3233/JAD-2012-129045  0.793
2013 Perry G, Rodrigues R, Castellani RJ. Are Alzheimer's Disease and Aging Evolutionary? Journal of Alzheimer's Disease. 35: 637-637. DOI: 10.3233/Jad-130090  0.304
2013 Mohorovic L, Perry G, Lavezzi AM, Stifter S, Malatestinic D, Micovic V, Materljan E, Haller H, Petrovic O. P4-353: Methemoglobin catabolism and Alzheimer's disease Alzheimer's & Dementia. 9: P861-P861. DOI: 10.1016/j.jalz.2013.08.187  0.457
2013 Wang X, Zhu X, Perry G, Wang W, Casadesus G, Lee H. P2-014: Presenilin mutations impair mitochondrial dynamics in neurons Alzheimer's & Dementia. 9: P349-P350. DOI: 10.1016/J.Jalz.2013.05.656  0.786
2013 Phelix C, LeBaron R, Roberson D, Villareal G, Perry G. P2-003: Flux and metabolite pathway mapping in the aging and Alzheimer's disease hippocampus Alzheimer's & Dementia. 9: P346-P347. DOI: 10.1016/J.Jalz.2013.05.645  0.389
2013 Bonda D, Stone J, Richardson S, Siedlak S, Perry G, Casadesus G, Smith M, Zhu X, Lee H. P3-067: Neuronal leptin resistance in Alzheimer's disease Alzheimer's & Dementia. 9: P574-P575. DOI: 10.1016/J.Jalz.2013.05.1137  0.826
2013 Joseph JA, Casadesus G, Smith MA, Perry G, Shukitt-Hale B. Nutrients and Food Constituents in Cognitive Decline and Neurodegenerative Disease Nutrition in the Prevention and Treatment of Disease. 373-390. DOI: 10.1016/B978-0-12-391884-0.00020-2  0.703
2013 Bonda DJ, Castellani RJ, Lee HG, Tabaton M, Casadesus G, Perry G, Zhu X, Smith MA. Down syndrome and Alzheimer disease: A "multi-hit" hypothesis based on multiple contributing factors resulting in pleotrophic consequences Alzheimer's Disease Research Compendium. 183-193.  0.713
2012 Candeias E, Duarte AI, Carvalho C, Correia SC, Cardoso S, Santos RX, Plácido AI, Perry G, Moreira PI. The impairment of insulin signaling in Alzheimer's disease. Iubmb Life. 64: 951-7. PMID 23129399 DOI: 10.1002/Iub.1098  0.814
2012 Miklossy J, Donta S, Mueller K, Nolte O, Perry G. Chronic or late lyme neuroborreliosis: present and future. The Open Neurology Journal. 6: 78. PMID 23091567 DOI: 10.2174/1874205X01206010078  0.329
2012 Rodrigues R, Smith MA, Wang X, Perry G, Lee HG, Zhu X, Petersen RB. Molecular neuropathogenesis of Alzheimer's disease: an interaction model stressing the central role of oxidative stress. Future Neurology. 7: 287-305. PMID 23086377 DOI: 10.2217/Fnl.12.27  0.828
2012 Castellani RJ, Perry G. Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress. Archives of Medical Research. 43: 694-8. PMID 23085451 DOI: 10.1016/j.arcmed.2012.09.009  0.68
2012 Morelli L, Perry G, Tagliavini F. The contribution of the amyloid hypothesis to the understanding of Alzheimer's disease: a critical overview. International Journal of Alzheimer's Disease. 2012: 709613. PMID 22970405 DOI: 10.1155/2012/709613  0.484
2012 Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, Ahn HJ, Ait-Mohamed O, Ait-Si-Ali S, Akematsu T, Akira S, ... ... Perry G, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 8: 445-544. PMID 22966490 DOI: 10.4161/Auto.19496  0.774
2012 Greco SJ, Hamzelou A, Johnston JM, Richardson S, Smith MA, Perry G, Ashford JW, Tezapsidis N. Isotyping the human TOMM40 variable-length polymorphism by gene amplification and restriction digest. Current Alzheimer Research. 9: 1168-73. PMID 22950840 DOI: 10.2174/156720512804142921  0.557
2012 Liu G, Men P, Zhu X, Perry G. Iron chelation and nanoparticle target delivery in the development of new multifunctional disease-modifying drugs for Alzheimer's disease. Therapeutic Delivery. 3: 571-4. PMID 22834400 DOI: 10.4155/tde.12.32  0.655
2012 Mondragón-Rodríguez S, Perry G, Zhu X, Moreira PI, Williams S. Glycogen synthase kinase 3: a point of integration in Alzheimer's disease and a therapeutic target? International Journal of Alzheimer's Disease. 2012: 276803. PMID 22779025 DOI: 10.1155/2012/276803  0.799
2012 Piccini A, Borghi R, Guglielmotto M, Tamagno E, Cirmena G, Garuti A, Pollero V, Cammarata S, Fornaro M, Messa M, Colombo L, Salmona M, Perry G, Tabaton M. β-amyloid 1-42 induces physiological transcriptional regulation of BACE1. Journal of Neurochemistry. 122: 1023-31. PMID 22708832 DOI: 10.1111/J.1471-4159.2012.07834.X  0.632
2012 Nunomura A, Moreira PI, Castellani RJ, Lee HG, Zhu X, Smith MA, Perry G. Oxidative damage to RNA in aging and neurodegenerative disorders. Neurotoxicity Research. 22: 231-48. PMID 22669748 DOI: 10.1007/s12640-012-9331-x  0.81
2012 Williams WM, Castellani RJ, Weinberg A, Perry G, Smith MA. Do β-defensins and other antimicrobial peptides play a role in neuroimmune function and neurodegeneration? Thescientificworldjournal. 2012: 905785. PMID 22606066 DOI: 10.1100/2012/905785  0.7
2012 Mondragón-Rodríguez S, Perry G, Zhu X, Boehm J. Amyloid Beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy. International Journal of Alzheimer's Disease. 2012: 630182. PMID 22482074 DOI: 10.1155/2012/630182  0.848
2012 Castellani RJ, Moreira PI, Perry G, Zhu X. The role of iron as a mediator of oxidative stress in Alzheimer disease. Biofactors (Oxford, England). 38: 133-8. PMID 22447715 DOI: 10.1002/biof.1010  0.81
2012 Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA. Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases. Advances in Experimental Medicine and Biology. 724: 205-21. PMID 22411245 DOI: 10.1007/978-1-4614-0653-2_16  0.828
2012 Reed-Cossairt A, Zhu X, Lee HG, Reed C, Perry G, Petersen RB. Alzheimer's disease and vascular deficiency: lessons from imaging studies and down syndrome. Current Gerontology and Geriatrics Research. 2012: 929734. PMID 22400025 DOI: 10.1155/2012/929734  0.817
2012 Perry G, Phelix CF, Nunomura A, Colom LV, Castellani RJ, Petersen RB, Lee HG, Zhu X. Untangling the vascular web from Alzheimer disease and oxidative stress. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 39: 4. PMID 22384486 DOI: 10.1017/S0317167100012609  0.836
2012 Nunomura A, Tamaoki T, Motohashi N, Nakamura M, McKeel DW, Tabaton M, Lee HG, Smith MA, Perry G, Zhu X. The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons. Journal of Neuropathology and Experimental Neurology. 71: 233-41. PMID 22318126 DOI: 10.1097/NEN.0b013e318248e614  0.824
2012 Zhu X, Castellani RJ, Ziats NP, Petersen RB, Gon Lee H, Perry G. Mark A. Smith: neurocytochemistry innovator. Journal of Neurochemistry. 120: 1139-40. PMID 22268813 DOI: 10.1111/J.1471-4159.2012.07656.X  0.721
2012 Bonda DJ, Liu G, Men P, Perry G, Smith MA, Zhu X. Nanoparticle delivery of transition-metal chelators to the brain: Oxidative stress will never see it coming! Cns & Neurological Disorders Drug Targets. 11: 81-5. PMID 22229318 DOI: 10.2174/187152712799960709  0.749
2012 Wang X, Yan MH, Fujioka H, Liu J, Wilson-Delfosse A, Chen SG, Perry G, Casadesus G, Zhu X. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Human Molecular Genetics. 21: 1931-44. PMID 22228096 DOI: 10.1093/Hmg/Dds003  0.791
2012 Santos RX, Correia SC, Zhu X, Lee HG, Petersen RB, Nunomura A, Smith MA, Perry G, Moreira PI. Nuclear and mitochondrial DNA oxidation in Alzheimer's disease. Free Radical Research. 46: 565-76. PMID 22149654 DOI: 10.3109/10715762.2011.648188  0.827
2012 Zhu X, Castellani RJ, Moreira PI, Aliev G, Shenk JC, Siedlak SL, Harris PL, Fujioka H, Sayre LM, Szweda PA, Szweda LI, Smith MA, Perry G. Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover. Free Radical Biology & Medicine. 52: 699-704. PMID 22137893 DOI: 10.1016/J.Freeradbiomed.2011.11.004  0.839
2012 Kudo W, Lee HP, Zou WQ, Wang X, Perry G, Zhu X, Smith MA, Petersen RB, Lee HG. Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death. Human Molecular Genetics. 21: 1138-44. PMID 22100763 DOI: 10.1093/Hmg/Ddr542  0.816
2012 Sheng B, Wang X, Su B, Lee HG, Casadesus G, Perry G, Zhu X. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease. Journal of Neurochemistry. 120: 419-29. PMID 22077634 DOI: 10.1111/J.1471-4159.2011.07581.X  0.813
2012 Calderón-Garcidueas L, Kavanaugh M, Block M, D'Angiulli A, Delgado-Chávez R, Torres-Jardón R, González-Maciel A, Reynoso-Robles R, Osnaya N, Villarreal-Calderon R, Guo R, Hua Z, Zhu H, Perry G, Diaz P. Neuroinflammation, hyperphosphorylated tau, diffuse amyloid plaques, and down-regulation of the cellular prion protein in air pollution exposed children and young adults Journal of Alzheimer's Disease. 28: 93-107. PMID 21955814 DOI: 10.3233/Jad-2011-110722  0.423
2012 Guglielmotto M, Aragno M, Tamagno E, Vercellinatto I, Visentin S, Medana C, Catalano MG, Smith MA, Perry G, Danni O, Boccuzzi G, Tabaton M. AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation. Neurobiology of Aging. 33: 196.e13-27. PMID 20638753 DOI: 10.1016/j.neurobiolaging.2010.05.026  0.75
2012 Perry G. Journal of huntington's disease -The family gets bigger Journal of Alzheimer's Disease. 30: 735. DOI: 10.3233/JAD-2012-129909  0.34
2012 Alonso AD, Gong C, Perry G, Avila J. Inge Grundke-Iqbal: A Legacy of Tau in the Etiology of Alzheimer Disease (1937–2012) Journal of Alzheimer's Disease. 33: 1-2. DOI: 10.3233/JAD-122223  0.32
2012 Perry G, Zhu X, Smith MA, Sorensen A, Avila J. Preface: Alzheimer's disease: Advances for a new century Advances in Alzheimer's Disease. 3: 1. DOI: 10.3233/978-1-61499-154-0-1  0.786
2012 Perry G, Yan M, Fujioka H, Wilson-Delfosse A, Chen S, Casadesus G, Zhu X, Wang X, Liu J. LRRK2 Directly Interacts with DLP1 to Regulate Mitochondrial Dynamics and Function Microscopy and Microanalysis. 18: 196-197. DOI: 10.1017/S1431927612002838  0.774
2012 Duran J, Perez-Cordova M, Pacheco-Otalora L, Perry G, Colom L. P4-108: Beta-amyloid reduces the expression of antioxidant repair genes Alzheimer's & Dementia. 8: P670-P670. DOI: 10.1016/j.jalz.2012.05.1811  0.302
2012 Lee HG, Perry G, Zhu X. Mark Smith: Pioneer of Alzheimer disease research Neurotoxicity Research. 22: 181. DOI: 10.1007/s12640-012-9341-8  0.79
2011 Wise-Scira O, Xu L, Kitahara T, Perry G, Coskuner O. Amyloid-β peptide structure in aqueous solution varies with fragment size. The Journal of Chemical Physics. 135: 205101. PMID 22128957 DOI: 10.1063/1.3662490  0.342
2011 Ziats NP, Petersen RB, Lee HG, Castellani RJ, Perry G, Zhu X. Mark A. Smith, 1965-2010: consummate student of pathogenesis. International Journal of Clinical and Experimental Pathology. 4: 731-2. PMID 22076176  0.758
2011 Colom LV, Castaneda MT, Hernandez S, Perry G, Jaime S, Touhami A. Intrahippocampal amyloid-β (1-40) injections injure medial septal neurons in rats. Current Alzheimer Research. 8: 832-40. PMID 22044024 DOI: 10.2174/156720511798192763  0.386
2011 Ashford JW, Salehi A, Furst A, Bayley P, Frisoni GB, Jack CR, Sabri O, Adamson MM, Coburn KL, Olichney J, Schuff N, Spielman D, Edland SD, Black S, Rosen A, ... ... Perry G, et al. Imaging the Alzheimer brain. Journal of Alzheimer's Disease : Jad. 26: 1-27. PMID 21971448 DOI: 10.3233/Jad-2011-0073  0.449
2011 Castellani RJ, Gupta Y, Sheng B, Siedlak SL, Harris PL, Coller JM, Perry G, Lee HG, Tabaton M, Smith MA, Wang X, Zhu X. A novel origin for granulovacuolar degeneration in aging and Alzheimer's disease: parallels to stress granules. Laboratory Investigation; a Journal of Technical Methods and Pathology. 91: 1777-86. PMID 21968813 DOI: 10.1038/Labinvest.2011.149  0.839
2011 Castellani RJ, Petersen RB, Lee HG, Zhu X, Perry G. Mark A. Smith: the scientist, the man. International Journal of Experimental Pathology. 92: 297-8. PMID 21917030 DOI: 10.1111/J.1365-2613.2011.00785.X  0.841
2011 Liu Q, Xie F, Alvarado-Diaz A, Smith MA, Moreira PI, Zhu X, Perry G. Neurofilamentopathy in neurodegenerative diseases. The Open Neurology Journal. 5: 58-62. PMID 21915226 DOI: 10.2174/1874205X01105010058  0.836
2011 Bonda DJ, Smith MA, Perry G, Lee HG, Wang X, Zhu X. The mitochondrial dynamics of Alzheimer's disease and Parkinson's disease offer important opportunities for therapeutic intervention. Current Pharmaceutical Design. 17: 3374-80. PMID 21902671 DOI: 10.2174/138161211798072562  0.828
2011 Correia SC, Cardoso S, Santos RX, Carvalho C, Santos MS, Perry G, Smith MA, Moreira PI. New insights into the mechanisms of mitochondrial preconditioning-triggered neuroprotection. Current Pharmaceutical Design. 17: 3381-9. PMID 21902670 DOI: 10.2174/138161211798072490  0.794
2011 Stone JG, Casadesus G, Gustaw-Rothenberg K, Siedlak SL, Wang X, Zhu X, Perry G, Castellani RJ, Smith MA. Frontiers in Alzheimer's disease therapeutics. Therapeutic Advances in Chronic Disease. 2: 9-23. PMID 21743833 DOI: 10.1177/2040622310382817  0.848
2011 Stone JG, Siedlak SL, Tabaton M, Hirano A, Castellani RJ, Santocanale C, Perry G, Smith MA, Zhu X, Lee HG. The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies. Journal of Neuropathology and Experimental Neurology. 70: 578-87. PMID 21666500 DOI: 10.1097/Nen.0B013E3182204414  0.837
2011 Wang X, Su B, Liu W, He X, Gao Y, Castellani RJ, Perry G, Smith MA, Zhu X. DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson's disease. Aging Cell. 10: 807-23. PMID 21615675 DOI: 10.1111/J.1474-9726.2011.00721.X  0.802
2011 Bonda DJ, Castellani RJ, Zhu X, Nunomura A, Lee HG, Perry G, Smith MA. A novel perspective on tau in Alzheimer's disease. Current Alzheimer Research. 8: 639-42. PMID 21605042 DOI: 10.2174/156720511796717131  0.848
2011 Britton GB, Smith MA, Perry G, Sambamurti K, Jagannatha Rao KS. Drug discovery for neurodegenerative diseases: challenges and novel biochemical targets dedicated to the memory of Mark A. Smith for his inspiring contribution to Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 24: 1-2. PMID 21525570 DOI: 10.3233/Jad-2011-110021  0.694
2011 Valdez CM, Phelix CF, Smith MA, Perry G, Santamaria F. Modeling cholesterol metabolism by gene expression profiling in the hippocampus. Molecular Biosystems. 7: 1891-901. PMID 21451815 DOI: 10.1039/c0mb00282h  0.582
2011 Perry G, Zhu X. Mark Anthony Smith (1965-2010): Visionary, Alzheimer researcher, and editor-in-chief of the Journal of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 24: 1-2. PMID 21383496 DOI: 10.3233/JAD-2011-111437  0.71
2011 Bonda DJ, Lee HG, Blair JA, Zhu X, Perry G, Smith MA. Role of metal dyshomeostasis in Alzheimer's disease. Metallomics : Integrated Biometal Science. 3: 267-70. PMID 21298161 DOI: 10.1039/c0mt00074d  0.827
2011 Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA. Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease? Ageing Research Reviews. 10: 264-73. PMID 21262392 DOI: 10.1016/J.Arr.2011.01.001  0.799
2011 Castellani RJ, Nugent SL, Morrison AL, Zhu X, Lee HG, Harris PL, Bajić V, Sharma HS, Chen SG, Oettgen P, Perry G, Smith MA. CD3 in Lewy pathology: does the abnormal recall of neurodevelopmental processes underlie Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 23-6. PMID 20972807 DOI: 10.1007/S00702-010-0485-5  0.804
2011 Castellani R, Perry G, Lee H, Zhu X. Mark A. Smith: Scholar and Innovator European Journal of Histochemistry. 55: 2. DOI: 10.4081/ejh.2011.rem2  0.657
2011 Phelix CF, LeBaron RG, Roberson DJ, Villanueva RE, Villareal G, Rahimi OB, Siedlak S, Zhu X, Perry G. Transcriptome-To-Metabolome™ Biosimulation Reveals Human Hippocampal Hypometabolism with Age and Alzheimer’s Disease International Journal of Knowledge Discovery in Bioinformatics. 2: 1-18. DOI: 10.4018/Jkdb.2011040101  0.74
2011 Phelix CF, LeBaron RG, Roberson DJ, Villanueva RE, Villareal G, Rahimi OB, Siedlak S, Zhu X, Perry G. Transcriptome-To-Metabolome™ Biosimulation Reveals Human Hippocampal Hypometabolism with Age and Alzheimer’s Disease International Journal of Knowledge Discovery in Bioinformatics. 2: 1-18. DOI: 10.4018/ijkdb.2011040101  0.605
2011 Perry G. Journal of Parkinson's Disease – Birth of JAD's New Sister Journal of Alzheimer's Disease. 25: 1-1. DOI: 10.3233/JAD-2011-1439  0.353
2011 Castellani RJ, Lee HG, Petersen RB, Zhu X, Perry G. Pathological phenotype in familial neurodegenerative disease: Implications for families and therapeutic constructs Therapy. 8: 475-479. DOI: 10.2217/Thy.11.62  0.78
2011 Castellani RJ, Zhu X, Perry G. Alzheimer's disease therapy: A moving target Therapy. 8: 457-458. DOI: 10.2217/thy.11.56  0.758
2011 Rothenberg KG, Siedlak SL, Lee HG, Zhu X, Perry G, Smith MA. Neurodegenerative processes in Alzheimer's disease: An overview of pathogenesis with strategic biomarker potential Future Neurology. 6: 173-185. DOI: 10.2217/Fnl.10.81  0.837
2011 Carvalho C, Correia SC, Santos RX, Cardoso S, Moreira PI, Zhu X, Smith MA, Perry G. Association of mitochondrial signaling in Alzheimer's disease and hypoxia Molecular Aspects of Neurodegeneration and Neuroprotection. 50-61. DOI: 10.2174/978160805092511101010050  0.828
2011 Zhu X, Castellani RJ, Lee H, Petersen RB, Nunomura A, Tabaton M, Perry G. The concept of redox balance in Alzheimer's disease: Mark Anthony Smith 1965–2010 Redox Report. 16: 47-48. DOI: 10.1179/174329211X13020951739893  0.842
2011 Castellani RJ, Zhu X, Nunomura A, Perry G. In Memoriam: Mark A. Smith, PhD: Neuroscientist and Visionary Neuropathology. 31: 458-459. DOI: 10.1111/j.1440-1789.2011.01240.x  0.739
2011 Phelix CF, LeBaron RG, Roberson DJ, Villanueva RE, Villareal G, Rahimi OB, Siedlak S, Zhu X, Perry G. In vivo and in silico evidence: Hippocampal cholesterol metabolism decreases with aging and increases with Alzheimers disease modeling brain aging and disease Proceedings - Ieee International Conference On Data Mining, Icdm. 1064-1070. DOI: 10.1109/ICDMW.2011.98  0.64
2011 Perry G, Castellani RJ, Ziats NP, Petersen RB, Lee H, Zhu X. Mark A. Smith Alzheimer Disease & Associated Disorders. 25: 369-370. DOI: 10.1097/Wad.0B013E318231Cff1  0.726
2011 Castellani RJ, Zhu X, Perry G. Mark A. Smith, PhD: Renegade Scientist and Visionary Journal of Neuropathology & Experimental Neurology. 70: 495-497. DOI: 10.1097/NEN.0b013e31821d3b7a  0.576
2011 Perry G, Wang X, Smith M, Zhu X. Mitochondrial Abnormalities in Alzheimer Disease Microscopy and Microanalysis. 17: 200-201. DOI: 10.1017/S1431927611001875  0.331
2011 Wang X, Smith M, Perry G, Zhu X. Mitochondrial Fragmentation Mediates MPP+ Toxicity in Neurons: Implications for Parkinson's Disease Microscopy and Microanalysis. 17: 196-197. DOI: 10.1017/S1431927611001851  0.821
2011 Correia S, Casadesus G, LaManna J, Perry G, Zhu X, Smith M, Moreira P. P3-290: Neuroprotective effects of hypoxic preconditioning on streptozotocin-induced animal model of sporadic Alzheimer's disease Alzheimer's & Dementia. 7: S609-S609. DOI: 10.1016/J.Jalz.2011.05.1732  0.775
2011 Correia S, Perry G, Zhu X, Smith M, Moreira P. P3-146: Decline in mitochondrial bioenergetics underlies central insulin resistance in streptozocin-induced model of sporadic Alzheimer's disease Alzheimer's & Dementia. 7: S562-S562. DOI: 10.1016/J.Jalz.2011.05.1586  0.816
2011 Zhu X, Castellani RJ, Lee H, Perry G. The origin of oxidative stress in neurodegenerative disease: Mark Anthony Smith 1965–2010 Free Radical Biology and Medicine. 51: 248-249. DOI: 10.1016/J.FREERADBIOMED.2011.05.001  0.763
2011 Castellani RJ, Rolston RK, Zhu X, Petersen RB, Perry G. In Memoriam: Mark A. Smith, PhD Disease-a-Month. 57: 524-526. DOI: 10.1016/J.Disamonth.2011.07.001  0.658
2010 Clark TA, Lee HP, Rolston RK, Zhu X, Marlatt MW, Castellani RJ, Nunomura A, Casadesus G, Smith MA, Lee HG, Perry G. Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease. International Journal of Biomedical Science : Ijbs. 6: 225-227. PMID 21765811  0.85
2010 Dwyer BE, Zacharski LR, Balestra DJ, Lerner AJ, Perry G, Zhu X, Smith MA. Potential role of iron in a Mediterranean-style diet. Archives of Neurology. 67: 1286-7; author reply. PMID 20937965 DOI: 10.1001/archneurol.2010.245  0.685
2010 Borghi R, Piccini A, Barini E, Cirmena G, Guglielmotto M, Tamagno E, Fornaro M, Perry G, Smith MA, Garuti A, Tabaton M. Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 22: 771-5. PMID 20847436 DOI: 10.3233/Jad-2010-100729  0.77
2010 Correia SC, Carvalho C, Cardoso S, Santos RX, Santos MS, Oliveira CR, Perry G, Zhu X, Smith MA, Moreira PI. Mitochondrial preconditioning: a potential neuroprotective strategy. Frontiers in Aging Neuroscience. 2. PMID 20838473 DOI: 10.3389/Fnagi.2010.00138  0.815
2010 Buxton GA, Siedlak SL, Perry G, Smith MA. Mathematical modeling of microtubule dynamics: insights into physiology and disease. Progress in Neurobiology. 92: 478-83. PMID 20713128 DOI: 10.1016/J.Pneurobio.2010.08.003  0.711
2010 Zou WQ, Puoti G, Xiao X, Yuan J, Qing L, Cali I, Shimoji M, Langeveld JP, Castellani R, Notari S, Crain B, Schmidt RE, Geschwind M, Dearmond SJ, Cairns NJ, ... ... Perry G, et al. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Annals of Neurology. 68: 162-72. PMID 20695009 DOI: 10.1002/Ana.22094  0.78
2010 Bonda DJ, Mailankot M, Stone JG, Garrett MR, Staniszewska M, Castellani RJ, Siedlak SL, Zhu X, Lee HG, Perry G, Nagaraj RH, Smith MA. Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease. Redox Report : Communications in Free Radical Research. 15: 161-8. PMID 20663292 DOI: 10.1179/174329210X12650506623645  0.866
2010 Santos RX, Correia SC, Wang X, Perry G, Smith MA, Moreira PI, Zhu X. Alzheimer's disease: diverse aspects of mitochondrial malfunctioning. International Journal of Clinical and Experimental Pathology. 3: 570-81. PMID 20661404  0.838
2010 Storace D, Cammarata S, Borghi R, Sanguineti R, Giliberto L, Piccini A, Pollero V, Novello C, Caltagirone C, Smith MA, Bossù P, Perry G, Odetti P, Tabaton M. Elevation of {beta}-amyloid 1-42 autoantibodies in the blood of amnestic patients with mild cognitive impairment. Archives of Neurology. 67: 867-72. PMID 20625095 DOI: 10.1001/Archneurol.2010.137  0.745
2010 Moreira PI, Santos RX, Zhu X, Lee HG, Smith MA, Casadesus G, Perry G. Autophagy in Alzheimer's disease. Expert Review of Neurotherapeutics. 10: 1209-18. PMID 20586699 DOI: 10.1586/Ern.10.84  0.859
2010 Lee HP, Zhu X, Casadesus G, Castellani RJ, Nunomura A, Smith MA, Lee HG, Perry G. Antioxidant approaches for the treatment of Alzheimer's disease. Expert Review of Neurotherapeutics. 10: 1201-8. PMID 20586698 DOI: 10.1586/ern.10.74  0.838
2010 Moh CF, Siedlak SL, Tabaton M, Perry G, Castellani RJ, Smith MA. Paraffin-embedded tissue (PET) blot method: application to Alzheimer disease. Journal of Neuroscience Methods. 190: 244-7. PMID 20580647 DOI: 10.1016/J.Jneumeth.2010.05.010  0.789
2010 Avila J, Perry G, Martínez-Martín P. Prospects on the origin of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 20: 669-72. PMID 20505238 DOI: 10.3233/JAD-2010-1421  0.438
2010 Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA. Mitochondria: the missing link between preconditioning and neuroprotection. Journal of Alzheimer's Disease : Jad. 20: S475-85. PMID 20463394 DOI: 10.3233/Jad-2010-100669  0.79
2010 Santos RX, Correia SC, Wang X, Perry G, Smith MA, Moreira PI, Zhu X. A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 20: S401-12. PMID 20463393 DOI: 10.3233/Jad-2010-100666  0.843
2010 Poeggeler B, Sambamurti K, Siedlak SL, Perry G, Smith MA, Pappolla MA. A novel endogenous indole protects rodent mitochondria and extends rotifer lifespan. Plos One. 5: e10206. PMID 20421998 DOI: 10.1371/Journal.Pone.0010206  0.778
2010 Mondragón-Rodríguez S, Basurto-Islas G, Lee HG, Perry G, Zhu X, Castellani RJ, Smith MA. Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis. Expert Review of Neurotherapeutics. 10: 683-91. PMID 20420489 DOI: 10.1586/Ern.10.27  0.844
2010 Bonda DJ, Wang X, Perry G, Nunomura A, Tabaton M, Zhu X, Smith MA. Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology. 59: 290-4. PMID 20394761 DOI: 10.1016/J.Neuropharm.2010.04.005  0.865
2010 Gustaw-Rothenberg K, Lerner A, Bonda DJ, Lee HG, Zhu X, Perry G, Smith MA. Biomarkers in Alzheimer's disease: past, present and future. Biomarkers in Medicine. 4: 15-26. PMID 20387301 DOI: 10.2217/bmm.09.86  0.835
2010 Heath JE, Siedlak SL, Zhu X, Lee HG, Thakur A, Yan R, Perry G, Smith MA, Castellani RJ. Widespread distribution of reticulon-3 in various neurodegenerative diseases. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 30: 574-9. PMID 20374499 DOI: 10.1111/J.1440-1789.2010.01107.X  0.861
2010 Nakamura M, Shishido N, Nunomura A, Smith MA, Perry G, Akutsu H, Hayashi T. Specific reaction of Met 35 in amyloid beta peptide with hypochlorous acid. Free Radical Research. 44: 734-41. PMID 20370566 DOI: 10.3109/10715761003745954  0.764
2010 Lee HP, Zhu X, Liu G, Chen SG, Perry G, Smith MA, Lee HG. Divalent metal transporter, iron, and Parkinson's disease: a pathological relationship. Cell Research. 20: 397-9. PMID 20357807 DOI: 10.1038/Cr.2010.39  0.785
2010 Bonda DJ, Wang X, Perry G, Smith MA, Zhu X. Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies. Drugs & Aging. 27: 181-92. PMID 20210366 DOI: 10.2165/11532140-000000000-00000  0.845
2010 Bonda DJ, Lee HP, Lee HG, Friedlich AL, Perry G, Zhu X, Smith MA. Novel therapeutics for Alzheimer's disease: an update. Current Opinion in Drug Discovery & Development. 13: 235-46. PMID 20205057  0.842
2010 Nair NG, Perry G, Smith MA, Reddy VP. NMR studies of zinc, copper, and iron binding to histidine, the principal metal ion complexing site of amyloid-beta peptide. Journal of Alzheimer's Disease : Jad. 20: 57-66. PMID 20164601 DOI: 10.3233/JAD-2010-1346  0.577
2010 Wang X, Perry G, Smith MA, Zhu X. Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons. Neuro-Degenerative Diseases. 7: 56-9. PMID 20160460 DOI: 10.1159/000283484  0.827
2010 Smith MA, Zhu X, Tabaton M, Liu G, McKeel DW, Cohen ML, Wang X, Siedlak SL, Dwyer BE, Hayashi T, Nakamura M, Nunomura A, Perry G. Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. Journal of Alzheimer's Disease : Jad. 19: 363-72. PMID 20061651 DOI: 10.3233/Jad-2010-1239  0.826
2010 Valdez CM, Smith MA, Perry G, Phelix CF, Santamaria F. Cholesterol homeostasis markers are localized to mouse hippocampal pyramidal and granule layers. Hippocampus. 20: 902-5. PMID 20054815 DOI: 10.1002/hipo.20743  0.6
2010 Nunomura A, Tamaoki T, Tanaka K, Motohashi N, Nakamura M, Hayashi T, Yamaguchi H, Shimohama S, Lee HG, Zhu X, Smith MA, Perry G. Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease. Neurobiology of Disease. 37: 731-7. PMID 20034567 DOI: 10.1016/J.Nbd.2009.12.012  0.844
2010 Tabaton M, Perry G, Zhu X, Lee HG, Casadesus G, Smith MA. Memantine: "hypothesis testing" not "disease modifying" in Alzheimer's disease. The American Journal of Pathology. 176: 540-1. PMID 20019185 DOI: 10.2353/ajpath.2010.090856  0.836
2010 Moreira PI, Sayre LM, Zhu X, Nunomura A, Smith MA, Perry G. Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer disease. Methods in Molecular Biology (Clifton, N.J.). 610: 419-34. PMID 20013193 DOI: 10.1007/978-1-60327-029-8_25  0.823
2010 Liu G, Men P, Perry G, Smith MA. Nanoparticle and iron chelators as a potential novel Alzheimer therapy. Methods in Molecular Biology (Clifton, N.J.). 610: 123-44. PMID 20013176 DOI: 10.1007/978-1-60327-029-8_8  0.668
2010 Su B, Wang X, Lee HG, Tabaton M, Perry G, Smith MA, Zhu X. Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells. Neuroscience Letters. 468: 267-71. PMID 19914335 DOI: 10.1016/J.Neulet.2009.11.010  0.834
2010 Moreira PI, Carvalho C, Zhu X, Smith MA, Perry G. Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. Biochimica Et Biophysica Acta. 1802: 2-10. PMID 19853658 DOI: 10.1016/j.bbadis.2009.10.006  0.833
2010 Moreira PI, Zhu X, Wang X, Lee HG, Nunomura A, Petersen RB, Perry G, Smith MA. Mitochondria: a therapeutic target in neurodegeneration. Biochimica Et Biophysica Acta. 1802: 212-20. PMID 19853657 DOI: 10.1016/J.Bbadis.2009.10.007  0.826
2010 Gustaw-Rothenberg KA, Siedlak SL, Bonda DJ, Lerner A, Tabaton M, Perry G, Smith MA. Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study. Experimental Gerontology. 45: 47-52. PMID 19819324 DOI: 10.1016/J.Exger.2009.10.003  0.805
2010 Su B, Wang X, Zheng L, Perry G, Smith MA, Zhu X. Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochimica Et Biophysica Acta. 1802: 135-42. PMID 19799998 DOI: 10.1016/J.Bbadis.2009.09.013  0.814
2010 Tabaton M, Zhu X, Perry G, Smith MA, Giliberto L. Signaling effect of amyloid-beta(42) on the processing of AbetaPP. Experimental Neurology. 221: 18-25. PMID 19747481 DOI: 10.1016/j.expneurol.2009.09.002  0.814
2010 Smith MA, Perry G, Zhu X, Haoudi A. Neurodegenerative diseases: mechanisms and therapies. Journal of Biomedicine & Biotechnology. 2006: 47539. PMID 17047307 DOI: 10.1155/JBB/2006/47539  0.77
2010 Zhu X, Beal MF, Wang X, Perry G, Smith MA. Preface: Mitochondria and neurodegenerative diseases Journal of Alzheimer's Disease. 20: S253. DOI: 10.3233/Jad-2010-1424  0.813
2010 Smith M, Zhu X, Lee H, Castellani R, Perry G. The Importance of Histochemical Detection of Oxidative Damage in Tissue Microscopy and Microanalysis. 16: 1016-1017. DOI: 10.1017/S1431927610059866  0.768
2010 Castellani R, Moreira P, Aliev G, Shenk J, Siedlak S, Harris P, Sayre L, Szweda L, Zhu X, Smith M, Perry G, Szweda P. Hydroxynonenal-Generated Crosslinking Fluorophore and Mitochondria-derived Lipoic Acid Accumulation in Alzheimer Disease Reveal a Dichotomy of Protein Turnover Microscopy and Microanalysis. 16: 1014-1015. DOI: 10.1017/S1431927610059350  0.824
2010 Shenk JC, Smith MA, Castellani RJ, Moreira P, Aliev G, Siedlak SL, Harris PL, Sayre L, Szweda PA, Szweda LI, Perry G. P1-196: Lipid peroxidation markers are associated with granulovacuolar degeneration but not lipofuscin formation Alzheimer's & Dementia. 6: S230-S230. DOI: 10.1016/J.Jalz.2010.05.746  0.769
2010 Zhu X, Wang X, Su B, Protter A, Perry G, Smith MA. P3-459: Latrepirdine (Dimebon™) modulate mitochondrial dynamics in AD cell models Alzheimer's & Dementia. 6: S588-S588. DOI: 10.1016/J.Jalz.2010.05.2002  0.802
2010 Gustaw-Rothenberg KA, Siedlak SL, Perry G, Lerner A, Smith MA. P3-208: Total antioxidant status in newly diagnosed Alzheimer's patients: Population based study Alzheimer's & Dementia. 6: S512-S512. DOI: 10.1016/J.Jalz.2010.05.1707  0.717
2010 Gustaw-Rothenberg KA, Lerner A, Perry G, Siedlak SL, Zhu X, Smith MA. P3-204: MDA and GSH levels in newly diagnosed Alzheimer's disease patients: A population-based study Alzheimer's & Dementia. 6: S510-S511. DOI: 10.1016/J.Jalz.2010.05.1703  0.809
2010 Lee H, Lee H, Kudo W, Zhu X, Perry G, Smith MA. P2-316: Disturbance in AMP-activated protein kinase (AMPK) signaling pathway in Alzheimer's disease Alzheimer's & Dementia. 6: S406-S406. DOI: 10.1016/J.Jalz.2010.05.1367  0.813
2010 Bamburg JR, Bernstein BW, Davis RC, Goldsbury C, Maloney MT, Marsden IT, Minamide LS, Pak CW, Perry G, Podlisny MB, Selkoe DJ, Shaw AE, Siedlak SL, Whiteman IT. P2-219: ADF/cofilin-actin rods and synaptic loss in Alzheimer's disease Alzheimer's & Dementia. 6: S378-S378. DOI: 10.1016/J.Jalz.2010.05.1268  0.629
2010 Prakash Reddy V, Perry G, Smith MA. Brain composition: Age-related changes Encyclopedia of Neuroscience. 313-316. DOI: 10.1016/B978-008045046-9.00108-X  0.504
2010 Rodrigues R, Bonda DJ, Perry G, Castellani RJ, Casadesus G, Lee HG, Lee HP, Wang X, Zhu X, Petersen RB, Smith MA. Oxidative stress and neurodegeneration: An inevitable consequence of aging? Implications for therapy Brain Protection in Schizophrenia, Mood and Cognitive Disorders. 305-323. DOI: 10.1007/978-90-481-8553-5_10  0.801
2009 Cardoso S, Santos R, Correia S, Carvalho C, Zhu X, Lee HG, Casadesus G, Smith MA, Perry G, Moreira PI. Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets. Pharmaceuticals (Basel, Switzerland). 2: 250-286. PMID 27713238 DOI: 10.3390/Ph2030250  0.789
2009 Rolston RK, Perry G, Zhu X, Castellani RJ, Dwyer BE, Lee HG, Petersen RB, Smith MA. Iron: A Pathological Mediator of Alzheimer Disease? Agro Food Industry Hi-Tech. 19: 33-36. PMID 21544251  0.844
2009 Friedlich AL, Rolston RK, Zhu X, Marlatt MW, Castellani RJ, Nunomura A, Lee HG, Casadesus G, Perry G, Smith MA. Treatment advances in Alzheimer's disease based on the oxidative stress model. F1000 Medicine Reports. 1. PMID 20948726 DOI: 10.3410/M1-54  0.867
2009 Bonda DJ, Wang X, Gustaw-Rothenberg KA, Perry G, Smith MA, Zhu X. Mitochondrial Drugs for Alzheimer Disease. Pharmaceuticals (Basel, Switzerland). 2: 287-298. PMID 20657666 DOI: 10.3390/Ph2030287  0.857
2009 Liu G, Men P, Perry G, Smith MA. Chapter 5 - Development of iron chelator-nanoparticle conjugates as potential therapeutic agents for Alzheimer disease. Progress in Brain Research. 180: 97-108. PMID 20302830 DOI: 10.1016/S0079-6123(08)80005-2  0.658
2009 Perry G, Moreira PI, Siedlak SL, Nunomura A, Zhu X, Smith MA. Natural oxidant balance in Parkinson disease. Archives of Neurology. 66: 1445. PMID 20008647 DOI: 10.1001/Archneurol.2009.261  0.825
2009 Bonda DJ, Evans TA, Santocanale C, Llosá JC, Viña J, Bajic V, Castellani RJ, Siedlak SL, Perry G, Smith MA, Lee HG. Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease. Aging. 1: 382-8. PMID 19946466 DOI: 10.18632/AGING.100044  0.837
2009 Liu G, Men P, Perry G, Smith MA. Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease. Journal of Nanoneuroscience. 1: 42-55. PMID 19936278 DOI: 10.1166/JNS.2009.005  0.64
2009 Lee HP, Casadesus G, Zhu X, Lee HG, Perry G, Smith MA, Gustaw-Rothenberg K, Lerner A. All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease. Expert Review of Neurotherapeutics. 9: 1615-21. PMID 19903021 DOI: 10.1586/ern.09.86  0.83
2009 Carvalho C, Correia SC, Santos RX, Cardoso S, Moreira PI, Clark TA, Zhu X, Smith MA, Perry G. Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia. Journal of Bioenergetics and Biomembranes. 41: 433-40. PMID 19830532 DOI: 10.1007/S10863-009-9247-1  0.835
2009 Su B, Liu H, Wang X, Chen SG, Siedlak SL, Kondo E, Choi R, Takeda A, Castellani RJ, Perry G, Smith MA, Zhu X, Lee HG. Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease. Molecular Neurodegeneration. 4: 32. PMID 19627592 DOI: 10.1186/1750-1326-4-32  0.798
2009 Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, Zhu X. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 9090-103. PMID 19605646 DOI: 10.1523/Jneurosci.1357-09.2009  0.824
2009 Smith MA, Perry G. Commentary on "Perspective on a pathogenesis and treatment of Alzheimer's disease." Therapeutic strategies for Alzheimer's disease: the need for a new era of innovation. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 294-5. PMID 19595903 DOI: 10.1016/j.jalz.2006.07.002  0.69
2009 Castellani RJ, Lee HG, Siedlak SL, Nunomura A, Hayashi T, Nakamura M, Zhu X, Perry G, Smith MA. Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta. Journal of Alzheimer's Disease : Jad. 18: 447-52. PMID 19584435 DOI: 10.3233/Jad-2009-1151  0.844
2009 Cardoso S, Correia S, Santos RX, Carvalho C, Santos MS, Oliveira CR, Perry G, Smith MA, Zhu X, Moreira PI. Insulin is a two-edged knife on the brain. Journal of Alzheimer's Disease : Jad. 18: 483-507. PMID 19542630 DOI: 10.3233/Jad-2009-1155  0.781
2009 Dwyer BE, Stone ML, Gorman N, Sinclair PR, Perry G, Smith MA, Zhu X. Heme-a, the heme prosthetic group of cytochrome c oxidase, is increased in Alzheimer's disease. Neuroscience Letters. 461: 302-5. PMID 19539709 DOI: 10.1016/j.neulet.2009.06.007  0.782
2009 Dwyer BE, Smith MA, Richardson SL, Perry G, Zhu X. Down-regulation of aminolevulinate synthase, the rate-limiting enzyme for heme biosynthesis in Alzheimer's disease. Neuroscience Letters. 460: 180-4. PMID 19477221 DOI: 10.1016/j.neulet.2009.05.058  0.752
2009 Perez M, Santa-Maria I, Gomez de Barreda E, Zhu X, Cuadros R, Cabrero JR, Sanchez-Madrid F, Dawson HN, Vitek MP, Perry G, Smith MA, Avila J. Tau--an inhibitor of deacetylase HDAC6 function. Journal of Neurochemistry. 109: 1756-66. PMID 19457097 DOI: 10.1111/J.1471-4159.2009.06102.X  0.753
2009 Liu G, Men P, Kudo W, Perry G, Smith MA. Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease. Neuroscience Letters. 455: 187-90. PMID 19429118 DOI: 10.1016/J.Neulet.2009.03.064  0.832
2009 Castellani RJ, Zhu X, Lee HG, Smith MA, Perry G. Molecular pathogenesis of Alzheimer's disease: reductionist versus expansionist approaches. International Journal of Molecular Sciences. 10: 1386-406. PMID 19399255 DOI: 10.3390/ijms10031386  0.853
2009 Wang X, Su B, Zheng L, Perry G, Smith MA, Zhu X. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. Journal of Neurochemistry. 109: 153-9. PMID 19393022 DOI: 10.1111/J.1471-4159.2009.05867.X  0.819
2009 Reddy VP, Zhu X, Perry G, Smith MA. Oxidative stress in diabetes and Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 16: 763-74. PMID 19387111 DOI: 10.3233/JAD-2009-1013  0.778
2009 Tezapsidis N, Johnston JM, Smith MA, Ashford JW, Casadesus G, Robakis NK, Wolozin B, Perry G, Zhu X, Greco SJ, Sarkar S. Leptin: a novel therapeutic strategy for Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 16: 731-40. PMID 19387109 DOI: 10.3233/Jad-2009-1021  0.845
2009 Obrenovich ME, Morales LA, Cobb CJ, Shenk JC, Méndez GM, Fischbach K, Smith MA, Qasimov EK, Perry G, Aliev G. Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation. Journal of Cellular and Molecular Medicine. 13: 853-65. PMID 19292735 DOI: 10.1111/J.1582-4934.2008.00512.X  0.841
2009 Nunomura A, Hofer T, Moreira PI, Castellani RJ, Smith MA, Perry G. RNA oxidation in Alzheimer disease and related neurodegenerative disorders. Acta Neuropathologica. 118: 151-66. PMID 19271225 DOI: 10.1007/s00401-009-0508-1  0.807
2009 Perry G, Zhu X, Moreira PI, Smith MA. Altered redox balance in disease: can we change the new equilibria? Annals of Neurology. 65: 121-3. PMID 19259960 DOI: 10.1002/ana.21608  0.787
2009 Rajendran R, Minqin R, Ynsa MD, Casadesus G, Smith MA, Perry G, Halliwell B, Watt F. A novel approach to the identification and quantitative elemental analysis of amyloid deposits--insights into the pathology of Alzheimer's disease. Biochemical and Biophysical Research Communications. 382: 91-5. PMID 19258010 DOI: 10.1016/j.bbrc.2009.02.136  0.738
2009 Guglielmotto M, Aragno M, Autelli R, Giliberto L, Novo E, Colombatto S, Danni O, Parola M, Smith MA, Perry G, Tamagno E, Tabaton M. The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha. Journal of Neurochemistry. 108: 1045-56. PMID 19196431 DOI: 10.1111/j.1471-4159.2008.05858.x  0.737
2009 Dwyer BE, Zacharski LR, Balestra DJ, Lerner AJ, Perry G, Zhu X, Smith MA. Getting the iron out: phlebotomy for Alzheimer's disease? Medical Hypotheses. 72: 504-9. PMID 19195795 DOI: 10.1016/j.mehy.2008.12.029  0.77
2009 Lee HP, Zhu X, Zhu X, Skidmore SC, Perry G, Sayre LM, Smith MA, Lee HG. The essential role of ERK in 4-oxo-2-nonenal-mediated cytotoxicity in SH-SY5Y human neuroblastoma cells. Journal of Neurochemistry. 108: 1434-41. PMID 19183271 DOI: 10.1111/J.1471-4159.2009.05883.X  0.782
2009 Lee HG, Casadesus G, Nunomura A, Zhu X, Castellani RJ, Richardson SL, Perry G, Felsher DW, Petersen RB, Smith MA. The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. The American Journal of Pathology. 174: 891-7. PMID 19164506 DOI: 10.2353/Ajpath.2009.080583  0.82
2009 Siedlak SL, Casadesus G, Webber KM, Pappolla MA, Atwood CS, Smith MA, Perry G. Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease. Free Radical Research. 43: 156-64. PMID 19160110 DOI: 10.1080/10715760802644694  0.838
2009 Lee HG, Casadesus G, Zhu X, Castellani RJ, McShea A, Perry G, Petersen RB, Bajic V, Smith MA. Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease. Neurochemistry International. 54: 84-8. PMID 19114068 DOI: 10.1016/J.Neuint.2008.10.013  0.852
2009 Stone JG, Rolston RK, Ueda M, Lee HG, Richardson SL, Castellani RJ, Perry G, Smith MA. Evidence for the novel expression of human kallikrein-related peptidase 3, prostate-specific antigen, in the brain. International Journal of Clinical and Experimental Pathology. 2: 267-74. PMID 19079621  0.729
2009 Ramiro-Puig E, Casadesús G, Lee HG, Zhu X, McShea A, Perry G, Pérez-Cano FJ, Smith MA, Castell M. Neuroprotective effect of cocoa flavonoids on in vitro oxidative stress. European Journal of Nutrition. 48: 54-61. PMID 19043659 DOI: 10.1007/s00394-008-0761-4  0.779
2009 Lee HG, Zhu X, Casadesus G, Pallàs M, Camins A, O'Neill MJ, Nakanishi S, Perry G, Smith MA. The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival. Brain Research. 1249: 244-50. PMID 19026996 DOI: 10.1016/j.brainres.2008.10.055  0.826
2009 Aliev G, Liu J, Shenk JC, Fischbach K, Pacheco GJ, Chen SG, Obrenovich ME, Ward WF, Richardson AG, Smith MA, Gasimov E, Perry G, Ames BN. Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats. Journal of Cellular and Molecular Medicine. 13: 320-33. PMID 18373733 DOI: 10.1111/J.1582-4934.2008.00324.X  0.793
2009 Friedlich AL, Smith MA, Zhu X, Takeda A, Nunomura A, Moreira PI, Perry G. Oxidative Stress in Parkinson`s Disease The Open Pathology Journal. 3: 38-42. DOI: 10.2174/1874375700903010038  0.831
2009 Castellani RJ, Perry G, Smith MA. Is Alzheimer's disease a myth? When is disease a disease? Current Alzheimer Research. 6: 82. DOI: 10.2174/156720509787313925  0.764
2009 Casadesus G, Bryan KJ, Perry G, Smith MA. Involvement of gonadotropins in cognitive function: Implications for Alzheimer's disease Hormones, Cognition and Dementia: State of the Art and Emergent Therapeutic Strategies. 251-258. DOI: 10.1017/CBO9780511635700.027  0.603
2009 Moreira P, Siedlak S, Wang X, Santos M, Oliveira C, Tabaton M, Nunomura A, Szweda L, Aliev G, Perry G. Autophagocytosis of mitochondria is prominent in Alzheimer disease Journal of the Neurological Sciences. 283: 282. DOI: 10.1016/j.jns.2009.02.162  0.425
2009 Aliev G, Shenk J, Liu J, Puchowicz M, Xu K, Smith M, Siedlak S, Obrenovich M, Ames B, de la Torre J, Koistinaho J, LaManna J, Perry G. Preventative effect of mitochondrial antioxidants in apoe deficiency mouse model of brain hypoperfusion Journal of the Neurological Sciences. 283: 272. DOI: 10.1016/J.Jns.2009.02.126  0.791
2009 Perry G, Ames B, Aliev G. Is oxidative stress an initiator of mitochondrial failure and vascular hypoperfusion during aging and Alzheimer disease? Present and future Journal of the Neurological Sciences. 283: 270-271. DOI: 10.1016/J.Jns.2009.02.122  0.697
2009 Shenk JC, Castellani RJ, Moreira P, Aliev G, Siedlak SL, Harris PL, Sayre L, Szweda PA, Smith MA, Perry G. P2-186: Hydroxynonenal generated crosslinking fluorophores accumulate in Alzheimer's disease Alzheimer's & Dementia. 5: P315-P315. DOI: 10.1016/J.Jalz.2009.04.498  0.833
2009 Gustaw-Rothenberg K, Siedlak SL, Lee H, Castellani RJ, Zhu X, Perry G, Petersen RB, Friedland RP, Lerner AJ, Smith MA. P3-073: Dissociated Aβ antibody level in newly diagnosed Alzheimer's disease: A population-based study Alzheimer's & Dementia. 5: P363-P363. DOI: 10.1016/J.Jalz.2009.04.1149  0.828
2009 Ramiro-Puig E, Casadesús G, Lee HG, Zhu X, McShea A, Perry G, Pérez-Cano FJ, Smith MA, Castell M. Neuroprotective effect of cocoa flavonoids on in vitro oxidative stress (European Journal of Nutrition (2008)) European Journal of Nutrition. 48: 61. DOI: 10.1007/s00394-008-0766-z  0.796
2009 Nunomura A, Takeda A, Moreira PI, Castellani RJ, Lee HG, Zhu X, Smith MA, Perry G. Neurofibrillary tangle formation as a protective response to oxidative stress in Alzheimer's disease Current Hypotheses and Research Milestones in Alzheimer's Disease. 103-113. DOI: 10.1007/978-0-387-87995-6_9  0.841
2009 Maccioni RB, Perry G. Preface Current Hypotheses and Research Milestones in Alzheimer's Disease. v-vi. DOI: 10.1007/978-0-387-87995-6  0.44
2008 Myung NH, Zhu X, Kruman II, Castellani RJ, Petersen RB, Siedlak SL, Perry G, Smith MA, Lee HG. Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes. Age (Dordrecht, Netherlands). 30: 209-15. PMID 19424844 DOI: 10.1007/S11357-008-9050-7  0.819
2008 Castellani RJ, Nunomura A, Rolston RK, Moreira PI, Takeda A, Perry G, Smith MA. Sublethal RNA oxidation as a mechanism for neurodegenerative disease. International Journal of Molecular Sciences. 9: 789-806. PMID 19325784 DOI: 10.3390/Ijms9050789  0.82
2008 Pallas M, Camins A, Smith MA, Perry G, Lee HG, Casadesus G. From aging to Alzheimer's disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8). Journal of Alzheimer's Disease : Jad. 15: 615-24. PMID 19096160 DOI: 10.3233/JAD-2008-15408  0.824
2008 Chan HW, Liu T, Verdile G, Bishop G, Haasl RJ, Smith MA, Perry G, Martins RN, Atwood CS. Copper Induces Apoptosis of Neuroblastoma Cells Via Post-translational Regulation of the Expression of Bcl-2-family Proteins and the tx Mouse is a Better Model of Hepatic than Brain Cu Toxicity. International Journal of Clinical and Experimental Medicine. 1: 76-88. PMID 19079689  0.783
2008 Su B, Wang X, Nunomura A, Moreira PI, Lee HG, Perry G, Smith MA, Zhu X. Oxidative stress signaling in Alzheimer's disease. Current Alzheimer Research. 5: 525-32. PMID 19075578 DOI: 10.2174/156720508786898451  0.857
2008 Aliev G, Obrenovich ME, Reddy VP, Shenk JC, Moreira PI, Nunomura A, Zhu X, Smith MA, Perry G. Antioxidant therapy in Alzheimer's disease: theory and practice. Mini Reviews in Medicinal Chemistry. 8: 1395-406. PMID 18991755 DOI: 10.2174/138955708786369582  0.836
2008 Marlatt MW, Lucassen PJ, Perry G, Smith MA, Zhu X. Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies. Journal of Alzheimer's Disease : Jad. 15: 199-210. PMID 18953109 DOI: 10.3233/Jad-2008-15206  0.846
2008 Aliev G, Gasimov E, Obrenovich ME, Fischbach K, Shenk JC, Smith MA, Perry G. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease. Vascular Health and Risk Management. 4: 721-30. PMID 18827923 DOI: 10.2147/Vhrm.S2608  0.842
2008 Bryan KJ, Zhu X, Harris PL, Perry G, Castellani RJ, Smith MA, Casadesus G. Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease. Molecular Neurodegeneration. 3: 13. PMID 18786268 DOI: 10.1186/1750-1326-3-13  0.831
2008 Perry G, Castellani RJ, Moreira PI, Lee HG, Zhu X, Smith MA. Pathology's new role: defining disease process and protective responses. International Journal of Clinical and Experimental Pathology. 1: 1-4. PMID 18784818  0.817
2008 Thakur A, Siedlak SL, James SL, Bonda DJ, Rao A, Webber KM, Camins A, Pallàs M, Casadesus G, Lee HG, Bowser R, Raina AK, Perry G, Smith MA, Zhu X. Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease. International Journal of Clinical and Experimental Pathology. 1: 134-46. PMID 18784806  0.825
2008 Gelfand SL, Vento M, Sastre J, Lust WD, Smith MA, Perry G, Walsh M, Martin R. A new model of oxidative stress in rat pups. Neonatology. 94: 293-9. PMID 18784426 DOI: 10.1159/000151649  0.568
2008 Castellani RJ, Nunomura A, Lee HG, Perry G, Smith MA. Phosphorylated tau: toxic, protective, or none of the above. Journal of Alzheimer's Disease : Jad. 14: 377-83. PMID 18688087 DOI: 10.3233/JAD-2008-14404  0.84
2008 Aliev G, Shenk JC, Fischbach K, Perry G. Stem cell niches as clinical targets: the future of anti-ischemic therapy? Nature Clinical Practice. Cardiovascular Medicine. 5: 590-1. PMID 18628773 DOI: 10.1038/ncpcardio1295  0.772
2008 Collingwood JF, Chong RK, Kasama T, Cervera-Gontard L, Dunin-Borkowski RE, Perry G, Pósfai M, Siedlak SL, Simpson ET, Smith MA, Dobson J. Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. Journal of Alzheimer's Disease : Jad. 14: 235-45. PMID 18560134 DOI: 10.3233/Jad-2008-14211  0.729
2008 Castellani RJ, Lee HG, Zhu X, Perry G, Smith MA. Alzheimer disease pathology as a host response. Journal of Neuropathology and Experimental Neurology. 67: 523-31. PMID 18520771 DOI: 10.1097/NEN.0b013e318177eaf4  0.851
2008 Friedland RP, Tedesco JM, Wilson AC, Atwood CS, Smith MA, Perry G, Zagorski MG. Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studies. The Journal of Biological Chemistry. 283: 22550-6. PMID 18505725 DOI: 10.1074/Jbc.M802088200  0.804
2008 Gustaw KA, Garrett MR, Lee HG, Castellani RJ, Zagorski MG, Prakasam A, Siedlak SL, Zhu X, Perry G, Petersen RB, Friedland RP, Smith MA. Antigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosis. Journal of Neurochemistry. 106: 1350-6. PMID 18485104 DOI: 10.1111/J.1471-4159.2008.05477.X  0.818
2008 Casadesus G, Rolston RK, Webber KM, Atwood CS, Bowen RL, Perry G, Smith MA. Menopause, estrogen, and gonadotropins in Alzheimer's disease. Advances in Clinical Chemistry. 45: 139-53. PMID 18429496 DOI: 10.1016/S0065-2423(07)00006-6  0.843
2008 Shah RS, Lee HG, Xiongwei Z, Perry G, Smith MA, Castellani RJ. Current approaches in the treatment of Alzheimer's disease. Biomedicine & Pharmacotherapy = Biomã©Decine & Pharmacothã©Rapie. 62: 199-207. PMID 18407457 DOI: 10.1016/j.biopha.2008.02.005  0.828
2008 Mondragón-Rodríguez S, Basurto-Islas G, Santa-Maria I, Mena R, Binder LI, Avila J, Smith MA, Perry G, García-Sierra F. Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease. International Journal of Experimental Pathology. 89: 81-90. PMID 18336525 DOI: 10.1111/J.1365-2613.2007.00568.X  0.665
2008 Perry G, Zhu X, Babar AK, Siedlak SL, Yang Q, Ito G, Iwatsubo T, Smith MA, Chen SG. Leucine-rich repeat kinase 2 colocalizes with alpha-synuclein in Parkinson's disease, but not tau-containing deposits in tauopathies. Neuro-Degenerative Diseases. 5: 222-4. PMID 18322396 DOI: 10.1159/000113708  0.824
2008 Moreira PI, Santos MS, Oliveira CR, Shenk JC, Nunomura A, Smith MA, Zhu X, Perry G. Alzheimer disease and the role of free radicals in the pathogenesis of the disease. Cns & Neurological Disorders Drug Targets. 7: 3-10. PMID 18289026 DOI: 10.2174/187152708783885156  0.877
2008 Su B, Wang X, Drew KL, Perry G, Smith MA, Zhu X. Physiological regulation of tau phosphorylation during hibernation. Journal of Neurochemistry. 105: 2098-108. PMID 18284615 DOI: 10.1111/J.1471-4159.2008.05294.X  0.814
2008 Gonzalez-Cuyar LF, Perry G, Miyajima H, Atwood CS, Riveros-Angel M, Lyons PF, Siedlak SL, Smith MA, Castellani RJ. Redox active iron accumulation in aceruloplasminemia. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 28: 466-71. PMID 18282164 DOI: 10.1111/J.1440-1789.2008.00901.X  0.798
2008 Moreira PI, Nunomura A, Nakamura M, Takeda A, Shenk JC, Aliev G, Smith MA, Perry G. Nucleic acid oxidation in Alzheimer disease. Free Radical Biology & Medicine. 44: 1493-505. PMID 18258207 DOI: 10.1016/J.Freeradbiomed.2008.01.002  0.849
2008 Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA, Ballabio A, Bamber BA, Bassham DC, Bergamini E, Bi X, Biard-Piechaczyk M, ... ... Perry G, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy. 4: 151-75. PMID 18188003 DOI: 10.4161/Auto.5338  0.768
2008 Sayre LM, Perry G, Smith MA. Oxidative stress and neurotoxicity. Chemical Research in Toxicology. 21: 172-88. PMID 18052107 DOI: 10.1021/Tx700210J  0.758
2008 Tamagno E, Guglielmotto M, Aragno M, Borghi R, Autelli R, Giliberto L, Muraca G, Danni O, Zhu X, Smith MA, Perry G, Jo DG, Mattson MP, Tabaton M. Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. Journal of Neurochemistry. 104: 683-95. PMID 18005001 DOI: 10.1111/J.1471-4159.2007.05072.X  0.82
2008 Zhu X, Siedlak SL, Wang Y, Perry G, Castellani RJ, Cohen ML, Smith MA. Neuronal binucleation in Alzheimer disease hippocampus. Neuropathology and Applied Neurobiology. 34: 457-65. PMID 17995921 DOI: 10.1111/J.1365-2990.2007.00908.X  0.818
2008 Mondragón-Rodríguez S, Mena R, Binder LI, Smith MA, Perry G, García-Sierra F. Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology. Neuropathology and Applied Neurobiology. 34: 62-75. PMID 17971079 DOI: 10.1111/J.1365-2990.2007.00853.X  0.688
2008 Evans TA, Siedlak SL, Lu L, Fu X, Wang Z, McGinnis WR, Fakhoury E, Castellani RJ, Hazen SL, Walsh WJ, Lewis AT, Salomon RG, Smith MA, Perry G, Zhu X. The Autistic Phenotype Exhibits a Remarkably Localized Modification of Brain Protein by Products of Free Radical-Induced Lipid Oxidation American Journal of Biochemistry and Biotechnology. 4: 61-72. DOI: 10.3844/Ajbbsp.2008.61.72  0.787
2008 Avila J, Perry G, Smith MA. Upcoming Meetings Related to Alzheimer's Disease* Journal of Alzheimer's Disease. 14: 459-460. DOI: 10.3233/Jad-2008-14416  0.692
2008 Gonzalez-Cuyar LF, Morrison AL, Perry G, DeJong JJ, Smith MA, Castellani RJ. Cerebrotendinous xanthomatosis: A critical update Future Neurology. 3: 491-501. DOI: 10.2217/14796708.3.4.491  0.702
2008 Bryan K, Lee HG, Perry G, Castellani RJ, Smith MA, Casadesus G. Nonestrogen-based hormonal therapies for Alzheimer's disease Future Neurology. 3: 399-407. DOI: 10.2217/14796708.3.4.399  0.783
2008 Bartocci M, Urlesberger B, Bel Fv, Lemmers P, Naulaers G, Hay WW, Mizuno K, Hida H, Masuda T, Nishino H, Togari H, Yang Q, Smith PB, Goldberg RN, Cotten CM, ... ... Perry G, et al. Contents Vol. 94, 2008 Neonatology. 94. DOI: 10.1159/000171888  0.515
2008 Bartocci M, Urlesberger B, Bel Fv, Lemmers P, Naulaers G, Hay WW, Mizuno K, Hida H, Masuda T, Nishino H, Togari H, Yang Q, Smith PB, Goldberg RN, Cotten CM, ... ... Perry G, et al. Subject Index Vol. 94, 2008 Neonatology. 94: 327-328. DOI: 10.1159/000171887  0.514
2008 Zhu X, Wang Y, Ogawa O, Lee HG, Raina AK, Fujioka H, Shimohama S, Atwood CS, Petersen RB, Perry G, Smith MA. Oral Presentations OP01: Neurodegenerative Diseases Journal of Neurochemistry. 81: 76-76. DOI: 10.1046/J.1471-4159.81.S1.44_1.X  0.84
2008 Aliev G, Liu J, Puchowicz M, Xu K, Siedlak S, Obrenovich M, Shenk J, Smith M, Gasimov E, LaManna J, Ames B, Perry G. DOES THE OXIDATIVE STRESS AND CEREBRAL ATHEROSCLEROSIS INITIATE BRAIN HYPOPERFUSION AND THE DEVELOPMENT OF ALZHEIMER DISEASE? Atherosclerosis Supplements. 9: 154. DOI: 10.1016/S1567-5688(08)70622-6  0.841
2008 Smith MA, Garrett MR, Lee H, Siedlak SL, Zhu X, Perry G, Friedland RP, Gustaw K. P1-351: A novel approach to diagnosis: Antigen-antibody disassociation in Alzheimer's disease Alzheimer's & Dementia. 4: T321-T321. DOI: 10.1016/J.Jalz.2008.05.933  0.812
2008 Moreira PI, Santos MS, Siedlak SL, Harris P, Smith MA, Aliev G, Perry G, Oliveira CR. P4-185: Mitochondrial dysfunction in Alzheimer's disease Alzheimer's & Dementia. 4: T725-T725. DOI: 10.1016/J.Jalz.2008.05.2252  0.832
2008 Aliev G, Shenk JC, Fischbach K, Cobb CJ, Pacheco GJ, Gasimov E, Perry G. P4-171: Cerebral hypoperfusion-induced oxidative stress and mitochondrial failure as initiators of aging and Alzheimer's disease pathology Alzheimer's & Dementia. 4: T721-T721. DOI: 10.1016/j.jalz.2008.05.2238  0.839
2008 Perry G, Cash AD, Harris PL, Siedlak SL, Smith MA, Zhu X. P4-170: Peroxidative nitrotyrosine formation in Alzheimer's disease Alzheimer's & Dementia. 4: T720-T720. DOI: 10.1016/J.Jalz.2008.05.2237  0.839
2008 Zhu X, Wang X, Su B, Fujioka H, Wang Y, Perry G, Smith MA. P4-166: Overexpression of amyloid precursor protein causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins Alzheimer's & Dementia. 4: T719-T719. DOI: 10.1016/J.Jalz.2008.05.2233  0.794
2008 Wang X, Su B, Smith MA, Perry G, Zhu X. P3-422: Impaired balance of mitochondrial fission and fusion in susceptible neurons of Alzheimer disease Alzheimer's & Dementia. 4: T645-T645. DOI: 10.1016/J.Jalz.2008.05.1993  0.832
2008 Lee H, Zhu X, Richardson SL, Perry G, Smith MA. P3-317: Failure in the control of cell cycle causes neurodegeneration Alzheimer's & Dementia. 4: T614-T615. DOI: 10.1016/j.jalz.2008.05.1886  0.751
2007 Webber KM, Casadesus G, Bowen RL, Perry G, Smith MA. Evidence for the role of luteinizing hormone in Alzheimer disease. Endocrine, Metabolic & Immune Disorders Drug Targets. 7: 300-3. PMID 18220951 DOI: 10.2174/187153007782794326  0.841
2007 Nunomura A, Moreira PI, Lee HG, Zhu X, Castellani RJ, Smith MA, Perry G. Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. Cns & Neurological Disorders Drug Targets. 6: 411-23. PMID 18220780 DOI: 10.2174/187152707783399201  0.851
2007 Nunomura A, Moreira PI, Takeda A, Smith MA, Perry G. Oxidative RNA damage and neurodegeneration. Current Medicinal Chemistry. 14: 2968-75. PMID 18220733 DOI: 10.2174/092986707782794078  0.813
2007 Castellani RJ, Perry G, Smith MA. The role of novel chitin-like polysaccharides in Alzheimer disease. Neurotoxicity Research. 12: 269-74. PMID 18201954 DOI: 10.1007/BF03033910  0.784
2007 Webber KM, Perry G, Smith MA, Casadesus G. The contribution of luteinizing hormone to Alzheimer disease pathogenesis. Clinical Medicine & Research. 5: 177-83. PMID 18056027 DOI: 10.3121/cmr.2007.741  0.837
2007 Wang X, Su B, Perry G, Smith MA, Zhu X. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease. Free Radical Biology & Medicine. 43: 1569-73. PMID 18037122 DOI: 10.1016/J.Freeradbiomed.2007.09.007  0.826
2007 Hayashi T, Shishido N, Nakayama K, Nunomura A, Smith MA, Perry G, Nakamura M. Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide. Free Radical Biology & Medicine. 43: 1552-9. PMID 17964426 DOI: 10.1016/j.freeradbiomed.2007.08.013  0.759
2007 Bishop GM, Smith MA, LaManna JC, Wilson AC, Perry G, Atwood CS. Iron homeostasis is maintained in the brain, but not the liver, following mild hypoxia. Redox Report : Communications in Free Radical Research. 12: 257-66. PMID 17961297 DOI: 10.1179/135100007X239270  0.787
2007 Nakamura M, Shishido N, Nunomura A, Smith MA, Perry G, Hayashi Y, Nakayama K, Hayashi T. Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron. Biochemistry. 46: 12737-43. PMID 17929832 DOI: 10.1021/bi701079z  0.788
2007 Moreira PI, Harris PL, Zhu X, Santos MS, Oliveira CR, Smith MA, Perry G. Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. Journal of Alzheimer's Disease : Jad. 12: 195-206. PMID 17917164 DOI: 10.3233/Jad-2007-12210  0.827
2007 Liu Q, Ju WK, Crowston JG, Xie F, Perry G, Smith MA, Lindsey JD, Weinreb RN. Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage. Investigative Ophthalmology & Visual Science. 48: 4580-9. PMID 17898281 DOI: 10.1167/iovs.07-0170  0.645
2007 Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, Smith MA, Zhu X, Perry G. Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy. 3: 614-5. PMID 17786024 DOI: 10.4161/Auto.4872  0.864
2007 Gonzalez-Cuyar LF, Hunter B, Harris PL, Perry G, Smith MA, Castellani RJ. Cerebrotendinous xanthomatosis: case report with evidence of oxidative stress. Redox Report : Communications in Free Radical Research. 12: 119-24. PMID 17623518 DOI: 10.1179/135100007X200173  0.811
2007 Zhu X, Su B, Wang X, Smith MA, Perry G. Causes of oxidative stress in Alzheimer disease. Cellular and Molecular Life Sciences : Cmls. 64: 2202-10. PMID 17605000 DOI: 10.1007/S00018-007-7218-4  0.86
2007 Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, Smith MA, Zhu X, Perry G. Autophagocytosis of mitochondria is prominent in Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 66: 525-32. PMID 17549012 DOI: 10.1016/J.Jns.2009.02.162  0.845
2007 Petersen RB, Nunomura A, Lee HG, Casadesus G, Perry G, Smith MA, Zhu X. Signal transduction cascades associated with oxidative stress in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 11: 143-52. PMID 17522439 DOI: 10.3233/Jad-2007-11202  0.854
2007 Castellani RJ, Moreira PI, Liu G, Dobson J, Perry G, Smith MA, Zhu X. Iron: the Redox-active center of oxidative stress in Alzheimer disease. Neurochemical Research. 32: 1640-5. PMID 17508283 DOI: 10.1007/S11064-007-9360-7  0.845
2007 Evans TA, Raina AK, Delacourte A, Aprelikova O, Lee HG, Zhu X, Perry G, Smith MA. BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease. International Journal of Medical Sciences. 4: 140-5. PMID 17505559 DOI: 10.7150/Ijms.4.140  0.849
2007 Castellani RJ, Zhu X, Lee HG, Moreira PI, Perry G, Smith MA. Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees? Expert Review of Neurotherapeutics. 7: 473-85. PMID 17492899 DOI: 10.1586/14737175.7.5.473  0.833
2007 Zhu X, Avila J, Perry G, Smith MA. Treating the lesions, not the disease. The American Journal of Pathology. 170: 1457-9. PMID 17456753 DOI: 10.2353/ajpath.2007.070193  0.789
2007 Thakur A, Wang X, Siedlak SL, Perry G, Smith MA, Zhu X. c-Jun phosphorylation in Alzheimer disease. Journal of Neuroscience Research. 85: 1668-73. PMID 17455299 DOI: 10.1002/Jnr.21298  0.823
2007 Casadesus G, Milliken EL, Webber KM, Bowen RL, Lei Z, Rao CV, Perry G, Keri RA, Smith MA. Increases in luteinizing hormone are associated with declines in cognitive performance. Molecular and Cellular Endocrinology. 269: 107-11. PMID 17376589 DOI: 10.1016/J.Mce.2006.06.013  0.788
2007 Casadesus G, Moreira PI, Nunomura A, Siedlak SL, Bligh-Glover W, Balraj E, Petot G, Smith MA, Perry G. Indices of metabolic dysfunction and oxidative stress. Neurochemical Research. 32: 717-22. PMID 17342408 DOI: 10.1007/S11064-007-9296-Y  0.852
2007 Zhu X, Smith MA, Honda K, Aliev G, Moreira PI, Nunomura A, Casadesus G, Harris PL, Siedlak SL, Perry G. Vascular oxidative stress in Alzheimer disease. Journal of the Neurological Sciences. 257: 240-6. PMID 17337008 DOI: 10.1016/J.Jns.2007.01.039  0.854
2007 Wung JK, Perry G, Kowalski A, Harris PL, Bishop GM, Trivedi MA, Johnson SC, Smith MA, Denhardt DT, Atwood CS. Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain. Current Alzheimer Research. 4: 67-72. PMID 17316167 DOI: 10.2174/156720507779939869  0.838
2007 Liu Q, Xie F, Rolston R, Moreira PI, Nunomura A, Zhu X, Smith MA, Perry G. Prevention and treatment of Alzheimer disease and aging: antioxidants. Mini Reviews in Medicinal Chemistry. 7: 171-80. PMID 17305591 DOI: 10.2174/138955707779802552  0.852
2007 Casadesus G, Smith MA, Basu S, Hua J, Capobianco DE, Siedlak SL, Zhu X, Perry G. Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease. Molecular Neurodegeneration. 2: 2. PMID 17241462 DOI: 10.1186/1750-1326-2-2  0.86
2007 Lee HG, Zhu X, Castellani RJ, Nunomura A, Perry G, Smith MA. Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses. The Journal of Pharmacology and Experimental Therapeutics. 321: 823-9. PMID 17229880 DOI: 10.1124/jpet.106.114009  0.838
2007 Zhu X, Lee HG, Perry G, Smith MA. Alzheimer disease, the two-hit hypothesis: an update. Biochimica Et Biophysica Acta. 1772: 494-502. PMID 17142016 DOI: 10.1016/j.bbadis.2006.10.014  0.841
2007 Webber KM, Casadesus G, Atwood CS, Bowen RL, Perry G, Smith MA. Gonadotropins: a cohesive gender-based etiology of Alzheimer disease. Molecular and Cellular Endocrinology. 260: 271-5. PMID 17052835 DOI: 10.1016/J.Mce.2006.01.018  0.829
2007 Previll LA, Crosby ME, Castellani RJ, Bowser R, Perry G, Smith MA, Zhu X. Increased expression of p130 in Alzheimer disease. Neurochemical Research. 32: 639-44. PMID 17006760 DOI: 10.1007/S11064-006-9146-3  0.824
2007 Bonda DJ, Webber KM, Siedlak SL, Perry G, Friedland RP, Smith MA. The Pathology of Alzheimer Disease Elicits an In Vivo Immunological Response American Journal of Immunology. 3: 10-14. DOI: 10.3844/Ajisp.2007.10.14  0.833
2007 Perry G, Smith MA. Sir Martin Roth – A Debt of Gratitude Journal of Alzheimer's Disease. 11: 1-1. DOI: 10.3233/JAD-2007-11101  0.522
2007 Perry G, Moreira PI, Siedlak SL, Santos MS, Oliveira CR, Fujioka H, Tabaton M, Nunomura A, Aliev G, Szweda LI, Smith MA. Mitochondrial autophagocytosis in Alzheimer disease Journal of Neuropathology and Experimental Neurology. 66: 434. DOI: 10.1097/01.Jnen.0000268871.37441.1B  0.839
2007 Perry G, Moreira PI, Harris PL, Zhu X, Santos MS, Oliveira CR, Smith MA. Lipoic acid and N-acetyl cysteine protect against mitochondrial-related oxidative stress in fibroblasts from Alzheimer disease patients Journal of Neuropathology and Experimental Neurology. 66: 434. DOI: 10.1097/01.Jnen.0000268870.37441.52  0.83
2007 Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, Smith MA, Zhu X, Perry G. Erratum: Autophagocytosis of mitochondria is prominent in Alzheimer disease (Journal of Neuropathology and Experimental Neurology (2007) 66, (525-532)) Journal of Neuropathology and Experimental Neurology. 66. DOI: 10.1097/01.Jnen.0000263876.99435.Cb  0.851
2007 Perry G, Moreira PI, Siedlak SL, Santos MS, Oliveira CR, Fujioka H, Tabaton M, Nunomura A, Aliev G, Szweda LI, Smith MA. Mitochondrial Autophagocytosis in Alzheimer Disease The Faseb Journal. 21. DOI: 10.1096/fasebj.21.5.a73-c  0.836
2007 Aliev G, Perry G, Shenk J, Puchowicz M, Xu K, Siedlak S, Obrenovich M, Smith M, Friedland R, Chen S, Ames B, Liu J, DeLaTore J, LaManna J, Koistinaho J. PO13-357 THE PRIMARY PATHOGENETIC ROLE OF VASCULAR HYPOPERFUSION, AND OXIDATIVE STRESS IN ALZHEIMER DISEASE Atherosclerosis Supplements. 8: 105. DOI: 10.1016/S1567-5688(07)71367-3  0.843
2007 Nunomura A, Perry G, Smith MA. Prospects for antioxidant therapy in mild cognitive impairment and alzheimer's disease Oxidative Stress and Neurodegenerative Disorders. 451-466. DOI: 10.1016/B978-044452809-4/50161-7  0.784
2007 Moreira PI, Nunomura A, Honda K, Aliev G, Casadesus G, Zhu X, Smith MA, Perry G. The key role of oxidative stress in alzheimer's disease Oxidative Stress and Neurodegenerative Disorders. 267-281. DOI: 10.1016/B978-044452809-4/50153-8  0.855
2007 Moreira PI, Smith MA, Zhu X, Nunomura A, Perry G. The potential application of antioxidant agents in Alzheimer disease therapeutics Pharmacological Mechanisms in Alzheimer's Therapeutics. 194-211. DOI: 10.1007/978-0-387-71522-3_12  0.83
2007 Liu G, Men P, Perry G, Smith MA. Nanoparticles for the Treatment of Alzheimer's Disease: Theoretical Rationale, Present Status and Future Perspectives Nanotechnologies For the Life Sciences. DOI: 10.1002/9783527610419.Ntls0122  0.614
2006 Smith MA, Zhu X, Lee HG, Harris PL, Fortino AE, Perry G, Castellani RJ. Sequestration of p27 within the cytoplasm of cardiac myocytes in chronic ischemic heart disease: pathogenic implications for ischemic cardiomyopathy. Age (Dordrecht, Netherlands). 28: 85-91. PMID 23598681 DOI: 10.1007/S11357-006-9001-0  0.798
2006 Franco S, Blasco MA, Siedlak SL, Harris PL, Moreira PI, Perry G, Smith MA. Telomeres and telomerase in Alzheimer's disease: epiphenomena or a new focus for therapeutic strategy? Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 2: 164-8. PMID 19595878 DOI: 10.1016/J.Jalz.2006.03.001  0.838
2006 Zhu X, Babar A, Siedlak SL, Yang Q, Ito G, Iwatsubo T, Smith MA, Perry G, Chen SG. LRRK2 in Parkinson's disease and dementia with Lewy bodies. Molecular Neurodegeneration. 1: 17. PMID 17137507 DOI: 10.1186/1750-1326-1-17  0.795
2006 Lee HG, Ueda M, Miyamoto Y, Yoneda Y, Perry G, Smith MA, Zhu X. Aberrant localization of importin alpha1 in hippocampal neurons in Alzheimer disease. Brain Research. 1124: 1-4. PMID 17070506 DOI: 10.1016/J.Brainres.2006.09.084  0.821
2006 Nunomura A, Honda K, Takeda A, Hirai K, Zhu X, Smith MA, Perry G. Oxidative damage to RNA in neurodegenerative diseases. Journal of Biomedicine & Biotechnology. 2006: 82323. PMID 17047315 DOI: 10.1155/Jbb/2006/82323  0.831
2006 Casadesus G, Puig ER, Webber KM, Atwood CS, Escuer MC, Bowen RL, Perry G, Smith MA. Targeting gonadotropins: an alternative option for Alzheimer disease treatment. Journal of Biomedicine & Biotechnology. 2006: 39508. PMID 17047306 DOI: 10.1155/Jbb/2006/39508  0.83
2006 Dwyer BE, Stone ML, Zhu X, Perry G, Smith MA. Heme deficiency in Alzheimer's disease: a possible connection to porphyria. Journal of Biomedicine & Biotechnology. 2006: 24038. PMID 17047301 DOI: 10.1155/JBB/2006/24038  0.781
2006 Webber KM, Stocco DM, Casadesus G, Bowen RL, Atwood CS, Previll LA, Harris PL, Zhu X, Perry G, Smith MA. Steroidogenic acute regulatory protein (StAR): evidence of gonadotropin-induced steroidogenesis in Alzheimer disease. Molecular Neurodegeneration. 1: 14. PMID 17018137 DOI: 10.1186/1750-1326-1-14  0.834
2006 Zhu X, Raina AK, Perry G, Smith MA. Apoptosis in Alzheimer disease: a mathematical improbability. Current Alzheimer Research. 3: 393-6. PMID 17017869 DOI: 10.2174/156720506778249470  0.83
2006 Perry G. Solving the insoluble. Journal of Alzheimer's Disease : Jad. 9: 301-4. PMID 17004366 DOI: 10.3233/JAD-2006-9S333  0.396
2006 Obrenovich ME, Smith MA, Siedlak SL, Chen SG, de la Torre JC, Perry G, Aliev G. Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions. Neurotoxicity Research. 10: 43-56. PMID 17000469 DOI: 10.1007/Bf03033333  0.825
2006 Lee HG, Ueda M, Zhu X, Perry G, Smith MA. Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway? Journal of Neuroscience Research. 84: 1856-61. PMID 16998902 DOI: 10.1002/jnr.21072  0.809
2006 Forero DA, Casadesus G, Perry G, Arboleda H. Synaptic dysfunction and oxidative stress in Alzheimer's disease: emerging mechanisms. Journal of Cellular and Molecular Medicine. 10: 796-805. PMID 16989739 DOI: 10.1111/J.1582-4934.2006.Tb00439.X  0.785
2006 Lam-Himlin D, Espey MG, Perry G, Smith MA, Castellani RJ. Malignant glioma progression and nitric oxide. Neurochemistry International. 49: 764-8. PMID 16971023 DOI: 10.1016/j.neuint.2006.07.001  0.717
2006 Lee HG, Zhu X, Nunomura A, Perry G, Smith MA. Amyloid-beta vaccination: testing the amyloid hypothesis?: heads we win, tails you lose! The American Journal of Pathology. 169: 738-9. PMID 16936250 DOI: 10.2353/ajpath.2006.060633  0.826
2006 Liu G, Men P, Harris PL, Rolston RK, Perry G, Smith MA. Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance. Neuroscience Letters. 406: 189-93. PMID 16919875 DOI: 10.1016/J.Neulet.2006.07.020  0.77
2006 Zhu X, Perry G, Moreira PI, Aliev G, Cash AD, Hirai K, Smith MA. Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. Journal of Alzheimer's Disease : Jad. 9: 147-53. PMID 16873962 DOI: 10.3233/JAD-2006-9207  0.832
2006 Zhu X, Siedlak SL, Smith MA, Perry G, Chen SG. LRRK2 protein is a component of Lewy bodies. Annals of Neurology. 60: 617-8; author reply . PMID 16847950 DOI: 10.1002/Ana.20928  0.766
2006 Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA. Involvement of oxidative stress in Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 65: 631-41. PMID 16825950 DOI: 10.1097/01.jnen.0000228136.58062.bf  0.854
2006 Lee HG, Perry G, Zhu X, Nunomura A, Smith MA. Amyloid-beta, BACE, and oxidative stress in Alzheimer's disease, a commentary on "The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression". Free Radical Biology & Medicine. 41: 188-9. PMID 16814097 DOI: 10.1016/j.freeradbiomed.2006.03.014  0.833
2006 Moreira PI, Zhu X, Nunomura A, Smith MA, Perry G. Therapeutic options in Alzheimer's disease. Expert Review of Neurotherapeutics. 6: 897-910. PMID 16784412 DOI: 10.1586/14737175.6.6.897  0.841
2006 Lee HG, Zhu X, Takeda A, Perry G, Smith MA. Emerging evidence for the neuroprotective role of alpha-synuclein. Experimental Neurology. 200: 1-7. PMID 16780837 DOI: 10.1016/J.Expneurol.2006.04.024  0.768
2006 Casadesus G, Garrett MR, Webber KM, Hartzler AW, Atwood CS, Perry G, Bowen RL, Smith MA. The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease. Drugs in R&D. 7: 187-93. PMID 16752944 DOI: 10.2165/00126839-200607030-00004  0.823
2006 Castellani RJ, Lee HG, Zhu X, Nunomura A, Perry G, Smith MA. Neuropathology of Alzheimer disease: pathognomonic but not pathogenic. Acta Neuropathologica. 111: 503-9. PMID 16718346 DOI: 10.1007/s00401-006-0071-y  0.859
2006 Nunomura A, Castellani RJ, Lee HG, Moreira PI, Zhu X, Perry G, Smith MA. Neuropathology in Alzheimer's disease: awaking from a hundred-year-old dream. Science of Aging Knowledge Environment : Sage Ke. 2006: pe10. PMID 16672726 DOI: 10.1126/sageke.2006.8.pe10  0.864
2006 Castellani RJ, Lee HG, Perry G, Smith MA. Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau. American Journal of Alzheimer's Disease and Other Dementias. 21: 126-30. PMID 16634469 DOI: 10.1177/153331750602100213  0.837
2006 Moreira PI, Zhu X, Liu Q, Honda K, Siedlak SL, Harris PL, Smith MA, Perry G. Compensatory responses induced by oxidative stress in Alzheimer disease. Biological Research. 39: 7-13. PMID 16629160 DOI: 10.4067/S0716-97602006000100002  0.873
2006 Hasegawa T, Matsuzaki-Kobayashi M, Takeda A, Sugeno N, Kikuchi A, Furukawa K, Perry G, Smith MA, Itoyama Y. Alpha-synuclein facilitates the toxicity of oxidized catechol metabolites: implications for selective neurodegeneration in Parkinson's disease. Febs Letters. 580: 2147-52. PMID 16567160 DOI: 10.1016/J.Febslet.2006.03.018  0.713
2006 Lee HG, Zhu X, Perry G, Smith MA. The fallacy of amyloid and cognition in Alzheimer's disease. Drugs & Aging. 23: 179. PMID 16536639 DOI: 10.2165/00002512-200623020-00007  0.82
2006 Zhu X, Lee HG, Moreira PI, Smith MA, Perry G. Presenilin mutation: a deadly first hit in Alzheimer disease. A commentary on "aging sensitizes towards ROS formation and lipid peroxidation in PS1M146L transgenic mice". Free Radical Biology & Medicine. 40: 737-9. PMID 16520226 DOI: 10.1016/j.freeradbiomed.2005.12.028  0.813
2006 Moreira PI, Zhu X, Lee HG, Honda K, Smith MA, Perry G. The (un)balance between metabolic and oxidative abnormalities and cellular compensatory responses in Alzheimer disease. Mechanisms of Ageing and Development. 127: 501-6. PMID 16516950 DOI: 10.1016/j.mad.2006.01.024  0.846
2006 Casadesus G, Webber KM, Atwood CS, Pappolla MA, Perry G, Bowen RL, Smith MA. Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochimica Et Biophysica Acta. 1762: 447-52. PMID 16503402 DOI: 10.1016/J.Bbadis.2006.01.008  0.831
2006 Lee HG, Zhu X, Nunomura A, Perry G, Smith MA. Amyloid beta: the alternate hypothesis. Current Alzheimer Research. 3: 75-80. PMID 16472207 DOI: 10.2174/156720506775697124  0.842
2006 Webber KM, Casadesus G, Zhu X, Obrenovich ME, Atwood CS, Perry G, Bowen RL, Smith MA. The cell cycle and hormonal fluxes in Alzheimer disease: a novel therapeutic target. Current Pharmaceutical Design. 12: 691-7. PMID 16472159 DOI: 10.2174/138161206775474305  0.858
2006 Strocchi P, Smith MA, Perry G, Tamagno E, Danni O, Pession A, Gaiba A, Dozza B. Clusterin up-regulation following sub-lethal oxidative stress and lipid peroxidation in human neuroblastoma cells. Neurobiology of Aging. 27: 1588-94. PMID 16464517 DOI: 10.1016/j.neurobiolaging.2005.09.019  0.618
2006 Moreira PI, Honda K, Zhu X, Nunomura A, Casadesus G, Smith MA, Perry G. Brain and brawn: parallels in oxidative strength. Neurology. 66: S97-101. PMID 16432155 DOI: 10.1212/01.wnl.0000192307.15103.83  0.863
2006 Perry G, Avila J, Kinoshita J, Smith MA. Alzheimer's disease: A century of scientific and clinical research Journal of Alzheimer's Disease. 9: 1-1. DOI: 10.3233/JAD-2006-9S301  0.641
2006 Moreira PI, Zhu X, Lee H, Nunomura A, Smith MA, Perry G. Therapeutic potential of oxidative stress reduction in Alzheimer's disease Future Neurology. 1: 1-4. DOI: 10.2217/14796708.1.1.1  0.84
2006 Smith M, Jagannathan Rao K, Perry G. Foreword: Apoptotic Mechanisms in Neurodegenerative Diseases Current Alzheimer Research. 3: 267-267. DOI: 10.2174/156720506778249443  0.658
2006 Sha O, Kwong WH, Dong M, Wang X, Chan AK, Burns AJ, Chan WY, Castellani RJ, Zhu X, Lee H, Perry G, Smith MA, Casadesus G, Kanaumi T, Ichinohe A, et al. Contents Vol. 4, 2006–2007 Neuroembryology and Aging. 4. DOI: 10.1159/000121404  0.755
2006 Castellani RJ, Zhu X, Lee HG, Perry G, Smith MA, Casadesus G. Neurogenesis in human hippocampus: Implications for Alzheimer disease pathogenesis Neuroembryology and Aging. 4: 175-182. DOI: 10.1159/000118927  0.826
2006 Smith MA, Moreira PI, Castellani RJ, Perry G. Symposium Brain Pathology. 14: 425-425. DOI: 10.1111/j.1750-3639.2004.tb00086.x  0.571
2006 Lee H, Ueda M, Zhu X, Perry G, Smith MA. P1-417: Ectopic localization of phospho-Smad2 in the vulnerable neurons of Alzheimer's disease Alzheimer's & Dementia. 2: S220-S220. DOI: 10.1016/j.jalz.2006.05.796  0.822
2006 Lee H, Ueda M, Zhu X, Perry G, Smith MA. P1-388: Failure of cytoplasmic-nuclear transport in Alzheimer's disease Alzheimer's & Dementia. 2: S211-S212. DOI: 10.1016/j.jalz.2006.05.766  0.803
2006 Webber KM, Casadesus G, Previll LA, Zhu X, Gregory C, Bowen R, Atwood CS, Perry G, Stocco DM, Smith MA. P1-369: Evidence of gonadotropin-induced steroidogenesis in Alzheimer's disease Alzheimer's & Dementia. 2: S206-S206. DOI: 10.1016/J.Jalz.2006.05.747  0.836
2006 Moreira PI, Siedlak SL, Santos MS, Oliveira CR, Fujioka H, Tabaton M, Nunomura A, Aliev G, Szweda LI, Zhu X, Smith MA, Perry G. O4-02-08: Mitochondrial autophagocytosis in Alzheimer disease Alzheimer's & Dementia. 2: S79-S79. DOI: 10.1016/J.Jalz.2006.05.307  0.82
2006 Moreira PI, Harris PL, Zhu X, Santos MS, Oliveira CR, Smith MA, Perry G. P3-375: Lipoic acid and N -acetyl cysteine protect against mitochondrial-related oxidative stress in fibroblasts from Alzheimer disease patients Alzheimer's & Dementia. 2: S486-S486. DOI: 10.1016/J.Jalz.2006.05.1645  0.83
2006 Lee H, Smith MA, Richardson SL, Perry G, Petersen RB. P3-372: Oxidative stress and prion protein mutations Alzheimer's & Dementia. 2: S485-S485. DOI: 10.1016/j.jalz.2006.05.1642  0.51
2006 Nunomura A, Chiba S, Yamaguchi H, Smith MA, Perry G. P3-369: Intraneuronal amyloid-β42 may silence oxidative stress in Alzheimer's disease Alzheimer's & Dementia. 2: S484-S484. DOI: 10.1016/j.jalz.2006.05.1639  0.823
2006 Casadesus G, Webber KM, Atwood CS, Bowen RL, Perry G, Smith MA. P3-296: Luteinizing hormone mediates Alzheimer-type changes in neurons Alzheimer's & Dementia. 2: S462-S462. DOI: 10.1016/J.Jalz.2006.05.1565  0.804
2006 Smith MA, Previll LA, Crosby ME, Zhu X, Bowser R, Perry G. P3-229: P130, a regulator of the G1 phase of the cell cycle, in Alzheimer disease: Evidence of a stuttered cell cycle Alzheimer's & Dementia. 2: S443-S443. DOI: 10.1016/J.Jalz.2006.05.1498  0.733
2005 Casadesus G, Smith MA, Perry G. Commentary: "Ceramide and cholesterol: possible connections between normal aging of the brain and Alzheimer's disease. Just hypotheses or molecular pathways to be identified?" by Claudio Costantini, Rekha M.K. Kolasani, and Luigi Puglielli. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 1: 51-2. PMID 19595817 DOI: 10.1016/j.jalz.2005.06.011  0.733
2005 Castellani RJ, Siedlak SL, Fortino AE, Perry G, Ghetti B, Smith MA. Chitin-like polysaccharides in Alzheimer's disease brains. Current Alzheimer Research. 2: 419-23. PMID 16248847 DOI: 10.2174/156720505774330555  0.81
2005 Moreira PI, Honda K, Liu Q, Santos MS, Oliveira CR, Aliev G, Nunomura A, Zhu X, Smith MA, Perry G. Oxidative stress: the old enemy in Alzheimer's disease pathophysiology. Current Alzheimer Research. 2: 403-8. PMID 16248845 DOI: 10.2174/156720505774330537  0.855
2005 Sayre LM, Moreira PI, Smith MA, Perry G. Metal ions and oxidative protein modification in neurological disease. Annali Dell'Istituto Superiore Di Sanitã . 41: 143-64. PMID 16244388  0.802
2005 Zhu X, Mei M, Lee HG, Wang Y, Han J, Perry G, Smith MA. P38 activation mediates amyloid-beta cytotoxicity. Neurochemical Research. 30: 791-6. PMID 16187214 DOI: 10.1007/s11064-005-6872-x  0.812
2005 Dwyer BE, Takeda A, Zhu X, Perry G, Smith MA. Ferric cycle activity and Alzheimer disease. Current Neurovascular Research. 2: 261-7. PMID 16181119 DOI: 10.2174/1567202054368371  0.847
2005 Moreira PI, Oliveira CR, Santos MS, Nunomura A, Honda K, Zhu X, Smith MA, Perry G. A second look into the oxidant mechanisms in Alzheimer's disease. Current Neurovascular Research. 2: 179-84. PMID 16181112 DOI: 10.2174/1567202053586758  0.861
Show low-probability matches.